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Abstract 
The intestinal epithelium spans proliferating crypts at its base to differentiated villi at the luminal surface 
and renews itself every 3-5 days. It maintains a dynamic equilibrium between proliferation, differentiation 
and apoptosis. The regulation of homeostasis, response to injury, regeneration and transformation is a 
complex set of dynamic processes. mRNA binding proteins (RBPs) are newly recognized regulators of 
intestinal homeostasis. The RBP:mRNA complexes act as rheostats of key signaling processes by 
regulating expression of already transcribed RNAs. Their functional effects are tissue and context 
dependent. The manner in which RBPs operate and their interactions with other pivotal pathways in 
colorectal cancer provide a framework for new insights and potential therapeutic applications. This thesis 
focuses upon the interplay between LIN28B and IGF2 mRNA binding protein (IMP1) in the regulation of 
intestinal epithelial regeneration and malignant transformation, unraveling a new perspective on these 
processes. 
LIN28B, an mRNA binding protein, plays a critical role in regulating growth and proliferation in the 
intestinal epithelium. Previous work in our lab revealed that LIN28B promotes growth and tumorigenesis 
of the intestinal epithelium via suppression of mature let-7 miRNAs. LIN28B suppression of let-7 
promotes upregulation of let-7 targets, including IMP1 (Insulin-like growth factor II mRNA-binding protein 
1). Our lab has shown that transgenic mice expressing LIN28B from the mouse Vil1 promoter (Vil-Lin28b 
mice) have increased proliferation and tumor formation in the small intestine. IMP1 protein levels are 
upregulated in these mice epithelia and tumors but specific role of IMP1 in Lin28b-mediated 
tumorigenesis remains unknown. The current study tested the hypothesis that IMP1 may be required for 
LIN28B-mediated tumorigenesis and that LIN28B and IMP1 may cooperatively promote a tumor-initiating 
phenotype. 
Additionally, IMP1 hypomorphic mice exhibit severe intestinal growth defects, yet it’s role in adult 
epithelium is unclear. We investigated the mechanistic contribution of epithelial IMP1 to intestinal 
homeostasis and repair. We evaluated IMP1 expression in Crohn’s disease patients followed by unbiased 
ribosome profiling in IMP1 knockout cells. We used irradiation and dextran sodium sulphate (DSS) 
induced colitis as injury models to evaluate regeneration in intestinal epithelium lacking IMP1. 
These studies show that in the context of LIN28B overexpression, IMP1 loss led to increased tumor 
initiation and progression. Ribosome profiling and RNA sequencing revealed a potential role for IMP1 in 
negatively regulating the Wnt pathway, stem cell signature and other pathways associated with 
proliferation. This pro-proliferative effect with the loss of IMP1 has been previously observed in breast 
cancer and intestinal stroma. Additionally, IMP1 acts as a post-transcriptional regulator of gut epithelial 
repair post-colitis and irradiation, in part through modulation of autophagy. This study provides a new 
perspective on post-transcriptional regulation of autophagy as a contributing factor to the pathogenesis 
of inflammatory bowel disease. 
In total, these studies provide new insights into the role of IMP1 in regulating homeostasis, response to 
injury, and tumorigenesis in the intestine. It provides evidence that IMP1 regulates the expression of its 
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THE ROLE OF INSULIN-LIKE GROWTH FACTOR-2 mRNA BINDING PROTEIN 1 
(IMP1) IN INTESTINAL EPITHELIAL HOMEOSTASIS 
 
 Priya Chatterji 
Anil K. Rustgi 
 
The intestinal epithelium spans proliferating crypts at its base to differentiated villi 
at the luminal surface and renews itself every 3-5 days. It maintains a dynamic 
equilibrium between proliferation, differentiation and apoptosis. The regulation of 
homeostasis, response to injury, regeneration and transformation is a complex set of 
dynamic processes. mRNA binding proteins (RBPs) are newly recognized regulators of 
intestinal homeostasis. The RBP:mRNA complexes act as rheostats of key signaling 
processes by regulating expression of already transcribed RNAs. Their functional effects 
are tissue and context dependent. The manner in which RBPs operate and their 
interactions with other pivotal pathways in colorectal cancer provide a framework for new 
insights and potential therapeutic applications. This thesis focuses upon the interplay 
between LIN28B and IGF2 mRNA binding protein (IMP1) in the regulation of intestinal 
epithelial regeneration and malignant transformation, unraveling a new perspective on 
these processes. 
LIN28B plays a critical role in regulating growth and proliferation in the intestinal 
epithelium. LIN28B suppression of let-7 promotes upregulation of let-7 targets, including 
IMP1 (Insulin-like growth factor II mRNA-binding protein 1). Mice expressing LIN28B 
from the mouse Vil1 promoter (Vil-Lin28b mice) have increased proliferation and tumor 
formation in the small intestine. IMP1 protein levels are upregulated in these mice 
epithelia and tumors but specific role of IMP1 in Lin28b-mediated tumorigenesis remains 
unknown.  
 2 
Additionally, IMP1 hypomorphic mice exhibit severe intestinal growth defects, yet 
it’s role in adult epithelium is unclear. We investigated the mechanistic contribution of 
epithelial IMP1 to intestinal homeostasis and repair. We evaluated IMP1 expression in 
Crohn’s disease patients followed by unbiased ribosome profiling in IMP1 knockout cells. 
We used irradiation and dextran sodium sulphate (DSS) induced colitis as injury models 
to evaluate regeneration in intestinal epithelium lacking IMP1. 
In total, these studies provide new insights into the role of IMP1 in regulating 
homeostasis, response to injury, and tumorigenesis in the intestine. It provides evidence 
that IMP1 regulates the expression of its targets at both the transcriptional and 



















CHAPTER I: INTRODUCTION 













The intestinal epithelium 
 
The intestinal epithelium is a layer of simple columnar cells that line the small 
and large intestine at the luminal surface. This epithelium forms a barrier against 
microorganisms and harmful substances while helping absorb nutrients and minerals 
and also secreting hormones and digestive peptides (all in the small intestine). The 
intestinal epithelium comprises two major structural components: the crypts that are 
invaginations in the epithelium and the villi that protrude into the lumen and house the 
differentiated cells. The crypts and villi help increase the surface area four-fold. 
The intestinal epithelium is one of the most proliferative organs and renews itself 
every 3-5 days. The intestinal epithelium consists of stem cells, absorptive cells and 
secretory cells. The crypt base is the compartment for two types of stem cells; the 
actively dividing crypt base columnar stem cells (CBCs), and the quiescent +4 stem 
cells. All intestinal lineages (absorptive and secretory) arise from the stem cells and 
migrate upwards towards the luminal surface except for Paneth cells that migrate 
towards the base. The secretory cells consist of Paneth cells (secreting anti-microbial 
peptides), goblet cells (secrete mucus), enteroendocrine cells (secreting hormones) and 
tuft cells (secrete cytokines). The absorptive enterocytes make up the majority of the 
epithelium and absorb micronutrients, water and electrolytes. The transit amplifying cells 
are immediate progeny of stem cells. The colon epithelium is similar to the small 
intestinal epithelium but lacks villi and serves to absorb remaining water and provide a 
barrier against micro-organisms (FIGURE 1).  
The crypt base columnar stem cells are actively dividing cells at the base of the 
crypts. Over the past decade, several markers of this population have been identified. 
Leu-rich repeat containing G protein-coupled receptor 5 (Lgr5), has been identified, 
through lineage tracing experiments, as an important selective marker for CBC cells in 
the small intestine and the colon (Barker et al. 2007). Other markers include Achaete-
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Scute homologue 2 (Ascl2), SPARC-related modular calcium-binding 2 (Smoc2), 
Prominin 1(Prom1), Musashi homologue 1 (Msi1), Olfactomedin 4 (Olfm4), and EphB2 
(Kim et al. 2017a). These cells can give rise to the entire epithelium in 60 days. They are 
radiosensitive and can be completely eliminated by radiation injury of 12Gy and above. 
The +4 stem cells on the other hand, are label retaining cells that are radio-resistant and 
can give rise to all the different cell types, including CBC cells when activated, especially 
in cases of injury. These cells are marked by Bmi1, Homeodomain-only (Hopx), Leu-rich 
repeats and immunoglobulin-like domains 1 (Lrig1), and telomerase reverse 
transcriptase (Tert) and Hopx. All markers of stem cells have been identified using 
lineage tracing experiments (Kim et al. 2017a).  
 The Paneth cells are secretory cells that are interspersed between the stem cells 
in the crypt base. They are characterized by the large eosinophilic refractive granules 
that occupy most of their cytoplasm. These granules are comprised of anti-microbial 
compounds and hormones that help maintaining the gastrointestinal barrier as well as 
secrete some hormones to aid the stem cells (Adolph et al. 2013; Clevers and Bevins 
2013). While the ablation of Paneth cells does not have any effect on the intestinal 
epithelium at homeostasis, loss of these cells impairs the regenerative response 
following injury (Parry et al. 2013). The other secretory cells include goblet, tuft and 
enteroendocrine cells. The goblet and tuft cells accumulate and respond to parasites 
and help restructure the intestinal barrier (Haber et al. 2017). The goblet cells mainly 
secrete mucus, a viscous fluid composed primarily of highly glycosylated proteins 
called mucins suspended in a solution of electrolytes. These cells are upregulated to 
help protect from chemical damage and shear stress as well as microbial infections 
(Specian and Oliver 1991). The tuft cells have been shown to play an important role in 
the innate immunity response (Grencis and Worthington 2016). Finally, enteroendocrine 
cells secrete gastrointestinal hormones or peptides that are diffused as messengers in 
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response to various stimuli. The secreted hormones include 
somatostatin, motilin, cholecystokinin, neurotensin, vasoactive intestinal peptide, 
and enteroglucagon, depending on the location of the cells within the gastrointestinal 
tract (Krause et al. 1985). The enterocytes constitute the absorptive cell population in the 
intestinal epithelium.  The cells have a glycocalyx surface coat and contain digestive 
enzymes. Their apical surface is lined with microvilli to increase surface area for the 
digestion and transport of molecules from the intestinal lumen. These cells help with 
uptake of water, sugars, ions, peptides and amino acids, lipids, vitamin B12 and bile 
salts among others (Washabau 2013).  
 Together the different cellular lineages help maintain a dynamic equilibrium and 
respond efficiently to stress and injury. This equilibrium is disturbed during inflammation 
and injury and can give rise to inflammatory bowel disorders (IBD). IBD is a complex 
disease that results from immunological responses and responses of the intestine to 
inflammation. Several different factors including genetic factors, diet, environment, 
microbiota, intestinal barrier defects and hormonal variability can contribute to the 
disease. Crohns and ulcerative colitis are the principal types of IBD. This disease 
manifests with several symptoms that may include abdominal pain, diarrhea, vomiting, 
rectal bleeding, muscle spasm/cramps, anemia, and weight loss. It is diagnosed and 
confirmed with biopsies during colonoscopies. Therapeutic interventions include anti-
inflammatory and immunosuppressive drugs, diet and lifestyle changes, microbiome 
changes and surgery . 
  In certain cases, IBD can be a risk factor for colorectal cancer (CRC). Globally, 
CRC affects more than 1 million people every year and remains the fourth most common 
cause of cancer related deaths worldwide (Cunningham et al. 2010).  It remains among 
the top causes of cancer-related deaths in the United States, with greater than 50,000 
deaths per year. Despite significant emphasis placed on improving early detection, only 
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40% of new CRC cases are diagnosed with localized-stage disease. The 5-year survival 
rate for regional and distal metastases is 68% and 11%, respectively, underscoring the 
importance of elucidating the underlying mechanisms for these invasive processes. The 
molecular events underlying colorectal cancer (CRC) progression are predicated upon 
alterations in oncogenes and tumor suppressor genes, however, new mechanisms for 
regulating these genes are still being discovered and may hold the promise for better 
diagnostic and/or therapeutic targets. 
RNA binding proteins as regulators of intestinal homeostasis 
 
An emerging node of regulation of intestinal epithelial homeostasis, response to 
injury, and malignant transformation, is through RNA binding proteins (RBP). Broadly 
speaking, RNA binding proteins (RBPs) are vital for regulation of several essential 
cellular processes such as RNA splicing, modifications, transport, localization, stability, 
degradation and translation (Wang et al. 2018). Several RBPs are expressed 
ubiquitously and are evolutionarily conserved (Gerstberger et al. 2014) to maintain their 
roles in basic cellular functions. Any significant change or disturbance in the RBPs 
regulating these essential cellular functions can lead to different diseases, including 
cancer (Wang et al. 2018).  RBPs function by binding to their target RNA, forming 
ribonucleoprotein (RNP) complexes (Dreyfuss et al. 2002) and regulating gene 
expression post-transcriptionally in a plethora of ways. Since RBPs can regulate already 
transcribed RNAs, they act in a rapid and efficient manner to alter gene expression, 
especially during changes in the microenvironment. A single RBP can bind to hundreds, 
if not thousands of targets, and a combination of several RNP interactions contribute to 
cellular identity and response to stimuli (Smith and Valcarcel 2000). RBPs can help 
recruit translation machinery to activate translation (Michlewski et al. 2008). By contrast, 
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RBPs involved in the RNA-induced silencing complex (miRISC) result in decapping, 
deadenylation and translational repression of the target mRNAs (Fabian et al. 2010). 
They can also suppress translation and induce degradation (Kim et al. 2009). In some 
cases, two RBPs can bind to the same RNA target to stabilize it, either enhancing or 
repressing translation (Sureban et al. 2007). RBPs can also have dichotomous functions 
where they can both enhance (Hamilton et al. 2013; Gutschner et al. 2014) or repress 
(Hamilton et al. 2015; Wang et al. 2016a) tumorigenesis depending upon the cellular 
context. Figure 2 shows a simplistic schematic of the functional consequences of mRBP 
binding to its targets. 
Structure of RNA binding proteins 
 The functional effects of conventional RNA binding proteins are dependent upon 
their binding to their target RNAs and forming ribonucleoprotein (RNP) complexes. The 
RNP complexes help with RNA processing, translation, export and localization. Since 
RBPs have multiple biological roles, their structures consist of multiple small domains. 
These consist of several types of RNA recognition and binding domains interspersed 
between catalytic domains to efficiently recognize a wide range of targets and regulate 
catalytic activity (Lunde et al. 2007). These catalytic domains include helicases, 
deaminases and RNAse III domains (Han et al. 2006; Nishikura 2010). Multiple RNA 
binding domains (RBDs) provide specificity to recognize and bind either long RNA 
sequences or sequences separated by many nucleotides or two different RNAs(Lunde et 
al. 2007). These can help form large complexes and regulate major signaling pathways. 
RBDs may comprise RNA recognition motifs (RRMs), dsRNA binding motifs (dsRBD), K-
homology domain (KH), Zinc fingers, S1 domain, Piwi and PAZ (PIWI, AGO, and Zwill) 
domains amongst others. RRM is by far the most common and well-characterized 
domain and most RBPs have multiple RRMs to provide specificity. By contrast, RBPs 
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involved in translation, such as initiation and elongation factors, bind all mRNAs and lack 
specificity (Lunde et al. 2007). RBPs can regulate subcellular localization of their targets 
due to nuclear and/or nucleolar localization signals (NLS/NoLS) or nuclear export signals 
(NES) depending upon their functional requirements(Rosenblum et al. 1998; Cassola et 
al. 2010). Overall, the structure of these conventional RBPs comprise multiple repeats of 
different RBDs with varying functional specificities and catalytic domains to regulate their 
target RNAs. 
 The target RNAs for RBPs are quite diverse. While RBPs can bind different 
regions of mRNAs (exonic, intronic, UTRs), there is increasing evidence of interactions 
with other types of RNAs, including non-coding RNAs, namely microRNAs, t-
RNAs, small interfering RNAs (siRNA), telomerase RNA, small nucleolar RNAs 
(snoRNAs), splicesomal small nuclear RNAs (snRNA), as well as the RNA moiety of the 
signal recognition particle (SRP RNA or 7SL RNA). These non-coding RNAs form 
extensive secondary structures to associate with proteins and regulate several 
processes like splicing, RNA modifications, protein localization and secretion as well as 
chromosomal maintenance (Hentze et al. 2018). 
 In recent years, advanced structural-analysis studies have provided evidence of 
complex protein–RNA interactions that do not require canonical RBDs (Hentze et al. 
2018). RNA interactome capture (RIC) (Castello et al. 2013) studies have identified ‘non-
conventional’ RBPs in several organisms that do not have discernible RBDs and have 
no known relationship to RNA biology(Hentze et al. 2018). Further studies have also 
shown that disordered protein regions can also facilitate protein-RNA interactions that 
can be specific or non-specific (Jarvelin et al. 2016). These unorthodox interactions can 
regulate RNA metabolism and different RNA processes, both co- and post- 
transcriptionally(Jarvelin et al. 2016). (The role of non-conventional or non-canonical 




LIN-28 was first discovered in C.elegans as a heterochronic gene that plays a 
vital role in developmental events (Ambros and Horvitz 1984). LIN28 has been studied in 
multiple species as a promoter of pluripotency. It has been shown to be expressed 
highly in undifferentiated tissues and its expression is downregulated as differentiation 
and development progress (Tsialikas and Romer-Seibert 2015). Hence, LIN28 is 
evolutionarily conserved to promote pluripotency and act as a ‘gatekeeper’ of 
differentiation. The most well studied mechanism of LIN28B function is via its interaction 
with the let-7 miRNAs (Balzeau et al. 2017).  
In mammals, there are two paralogs of LIN28; LIN28A and LIN28B that have 
mostly overlapping functions (Viswanathan and Daley 2010). LIN28A and LIN28B have 
a cysteine cysteine histidine cysteine (CCHC) zinc finger domain and a cold shock 
domain (Hafner et al. 2013). LIN28B also contains an extended C terminal region with a 
nuclear localization signal (NLS) (Piskounova et al. 2011) (Figure 3). In mice, LIN28 
proteins are expressed highly during embryonic development but their expression 
declines rapidly after E18.5 in the small intestine and colon correlating reciprocally with 
intestinal differentiation (Gregorieff and Clevers 2005; Madison et al. 2013b). In adult 
mice, LIN28B expression is limited to the crypt compartment (Madison et al. 2013b). 
This correlates with the reciprocal increase in the expression of the Let-7 microRNAs. 
LIN28B expression is observed in the nucleus of undifferentiated cells whereas low 
expression of LIN28B can be seen in the cytoplasm of differentiated intestinal cells. The 
constitutive knockout of either Lin28a or Lin28b causes dwarfism and a growth 
retardation phenotype in mice (Shinoda et al. 2013). The double knockout is 
synthetically lethal, and the mice do not survive past E12.5. This phenotype, however, is 
not observed when the genes are deleted in neonatal or adult mice (Shinoda et al. 
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2013). The intestinal epithelium specific single or double knockouts of Lin28a and Lin28b 
show no obvious intestinal phenotype (Tu et al. 2015). Furthermore, these mice also do 
not show any difference in susceptibility to colonic tumorigenesis with dextran sodium 
sulphate (DSS)/azoxymethane (AOM) when compared to their wild-type littermates (Tu 
et al. 2015). 
Several studies have shown that LIN28B is overexpressed in about 30% of 
colorectal tumors (King et al. 2011a; King et al. 2011b). LIN28B overexpression 
correlates with invasive tumor phenotype, worse survival and increased tumor 
recurrence in colorectal cancer (CRC) (Madison et al. 2013b; Madison et al. 2015; Tu et 
al. 2015). In mice, intestinal epithelial cell (IEC) specific Lin28b overexpression is 
sufficient to transform the epithelium and give rise to adenomas and adenocarcinomas 
between 9-12 months of age, which is accelerated by the concurrent knockout of Let7 
b1/c2 with faster and greater formation of adenocarcinomas within 6 months (Madison et 
al. 2013b; Madison et al. 2015).  LIN28B cooperates with Wnt signaling to increase 
tumor formation in carcinogen-induced mouse model of colitis-associated tumorigenesis 
(Tu et al. 2015). Furthermore, LIN28 overexpression increases tumor formation and 
decreases tumor latency in an Apc+/min model of colon cancer (Tu et al. 2015). LIN28A, 
which is structurally similar to LIN28B (Wang et al. 2016c), is upregulated in over 70% of 
CRC patients (Wang et al. 2016b) and overexpression of LIN28A is functionally similar 
to LIN28B (Tu et al. 2015). While silencing either LIN28 protein leads to increased 
apoptosis by targeting of anti-apoptotic BCL2L1 protein for degradation (Zhang et al. 
2018), LIN28A overexpression however, leads to increased chemosensitivity in CRC 
cells lines to 5FU (fluorouracil) treatment through induction of apoptosis (Wang et al. 
2016b).  In summary, LIN28B is critical in colorectal tumorigenesis and has been 
established to oncogenic effects in this context. While less studied in colorectal cancers, 
LIN28A has similar functions. 
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Insulin-like growth factor 2 mRNA binding protein 1 (IGF2BPs/IMPs) 
The insulin-like growth factor-2 mRNA binding proteins (IGF2BPs or IMPs) 
belong to a conserved subfamily of RBPs. The IMPs have been studied for their roles in 
regulation of post-transcriptional processes such as mRNA localization, turnover, and 
translational control (Nielsen et al. 2001; Yaniv and Yisraeli 2002). In mammals, the 
canonical domain structure of IMPs is similar. IMP1 and IMP3 are more closely related 
and have 73% sequence similarity whereas IMP2 shares 56% similarity (Bell et al. 2013) 
(Figure 3). IMPs contain 2 RRMs in their N-terminal region and 4 KH domains in the C-
terminal region(Nielsen et al. 1999). The KH domains are the primary RBDs while the 
RRMs are involved in stabilization of IMP-mRNA complexes (Nielsen et al. 2004; 
Wachter et al. 2013). The IMPs bind their targets in multiple low affinity higher-order 
complexes because KH domains allow recognition of only short stretches of RNA with 
relatively weak binding affinity (Chao et al. 2010). 
Imp proteins, especially Imp1, are expressed highly during development but expression 
is reduced drastically after post-natal day 12 in the small and large intestine. The adult 
mice retain low expression of IMP1 in the crypts (Hansen et al. 2004). IMP3, an isoform 
of IMP1, also follows a similar pattern of expression in the intestine (Mori et al. 2001). 
IMP2, by contrast, has been shown to be expressed postnatally (Dai et al. 2011) and is 
mainly found in Processing bodies (P bodies) in the cytoplasm (Lui et al. 2014). 
Similarly, Imp1 null mice show significant growth retardation at E17.5 and more than 
50% of the mice do not survive past post-natal day 3. The mice show impaired intestinal 
morphology and development (Hansen et al. 2004). By contrast, Imp2 null mice have no 
growth retardation but are highly resistant to diet induced obesity (Dai et al. 2015). In 
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colorectal cancer cell lines and fibroblasts, Imp2 deletion results in reduced proliferation 
(Dai et al. 2017). 
IMP1 plays a functional role in the RNA stability by binding and shielding several mRNAs 
that play critical roles in cell growth and proliferation from proteolytic degradation 
(Noubissi et al. 2006). IMP1 also regulates cell cycle progression and migration in 
human CRC cells (Boyerinas et al. 2008).  IMP1 is overexpressed in more than 80% of 
human CRC (Ross et al. 2001) and correlates with invasion, lymph node metastasis, 
and worse prognosis (Dimitriadis et al. 2007b; Hamilton et al. 2013; Madison et al. 
2013b). IMP1 overexpression in CRC cell lines causes a significant increase in tumor 
volume in xenograft models (Hamilton et al. 2013). By contrast, Imp1 loss in the stroma 
is associated with increased tumor number in the AOM-DSS model of colonic 
carcinogenesis. This dichotomous role of Imp1 is seen in other instances where IMP1 
stabilizes β-catenin mRNA in breast cancer cells (Gu et al. 2008) and is in turn activated 
by it in a feedback mechanism (Gu et al. 2009). In other studies, IMP1 was shown to 
bind and stabilize beta-TRCP1, a β-catenin antagonist in CRC cell lines (Elcheva et al. 
2009). IMP2 gene is amplified at a higher frequency in several solid tumors. IMP2 
depletion inhibits proliferation of mouse embryonic fibroblasts (MEFs) and well as 
several human cancer cell lines. It is also shown to stabilize oncogenic transcriptional 
regulator HMGA1 in MEFs (Dai et al. 2017). IMP3 expression has been shown to 
correlate with worse prognosis and increased recurrence in colon cancer patients(Li et 
al. 2009). It has also been associated with low progression-free survival in small-
intestinal neuroendocrine neoplasms (Massironi et al. 2017) and studied as an 
immunohistochemical marker in small intestinal adenocarcinomas (Daikuhara et al. 
2015). 
These studies imply divergent roles for IMP1, depending upon whether one considers 
the epithelial vs. stromal compartment. 
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Other RNA binding proteins in the intestine 
Several other mRNA binding proteins are increasingly being studied for their roles in 
intestinal homeostasis and disease. A few of the prominent ones are listed below. 
Musashi  
In the intestinal epithelium, the MSI family of proteins are expressed in the crypts 
in mice (Wang et al. 2015a). Their expression is observed in adult mice in both the 
active and reserve stem cell compartments (Li et al. 2014; Li et al. 2015). The MSI family 
of proteins consist of the functionally redundant MSI1 and MSI2. Ablation of Msi proteins 
(Msi1 or 2) in IEC, either individually or together, showed no changes in morphology, 
proliferation or differentiation (Yousefi et al. 2016). Although, intestinal epithelial specific 
double knockout of Msi1 and Msi2 (Msi1IEC Msi2IEC) in mice does not show any overt 
phenotype under basal conditions(Yousefi et al. 2016) .However, following 12Gy 
radiation injury, Msi1IEC Msi2IEC mice show a significant impairment in the regenerative 
response. MSI proteins are also up-regulated during activation of reserve intestinal stem 
cells and are required for lineage tracing from these cells under basal conditions by 
enabling their S-phase entry (Yousefi et al. 2016). MSI1 overexpression has been shown 
to induce tumorigenesis by activation of Wnt and Notch pathways in primary intestinal 
cells and xenograft models (Rezza et al. 2010). The overexpression of either MSI is 
sufficient to transform the intestinal epithelium and form tumors (Li et al. 2015; Wang et 
al. 2015a; Yousefi et al. 2016) via activation of the mTORC1 complex with inhibition of 
Pten (Li et al. 2015; Wang et al. 2015a). In patients with small intestinal 
adenocarcinomas, MSI1 is overexpressed in 71% of the tumors as compared to the 
normal tissue and correlated with depth of wall invasion (Wang et al. 2015c). In patients 
with Irritable bowel syndrome (IBS) the density of MSI1+ cells are significantly reduced 
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and correlates with dysfunctional stem cell potential (El-Salhy and Gilja 2017). MSI1+ 
cells have been shown to be involved in repair of the intestinal epithelium induced by 5-
FU (Luo et al. 2017). Due to their roles in EMT, stem cell identity, and oncogenesis, the 
MSI proteins have increasingly been linked to therapeutic resistance in cancer 
treatments (Han et al. 2015; de Araujo et al. 2016; Lee et al. 2016). This has resulted in 
efforts to develop inhibitors of MSI proteins as potential therapeutic targets (Clingman et 
al. 2014; Lan et al. 2015).  
 
HuR  
HuR , a member of ELAV family of RBPs (reviewed extensively in (Hinman and 
Lou 2008) ) consists of 2 RRM domains, a hinge region and a third RRM (Brennan and 
Steitz 2001) that helps it bind to adenylate uridylate (AU) rich regions in 3’ UTRs of 
target RNAs involved in cell survival and tumorigenesis(Brody and Gonye 2011). HuR is 
expressed throughout the intestinal epithelium in mice (Giammanco et al. 2014) (Liu et 
al. 2014a). Although mice with intestinal epithelial cell (IEC) knockout specific HuR show 
signs of mucosal atrophy, there are no changes in body weight or other abnormalities 
(Giammanco et al. 2014). These mice show reduction in proliferating cells in the 
intestine and shorter crypts and villi but are otherwise healthy and reproduce normally 
(Giammanco et al. 2014) (Liu et al. 2014a).  
 High HuR protein expression is found in both the nucleus and cytoplasm of 
human colon cancers (Denkert et al. 2006). While low HuR protein expression is 
observed in the normal colon (Young et al. 2009), it is increased significantly in the 
cytoplasm of colorectal tumors (Young et al. 2009). Mice with intestinal specific HuR 
deletion (HuRIEC) show increased injury in a doxorubicin induced acute injury model 
(Giammanco et al. 2014). These mice also show increased regeneration and 
compensatory proliferation during the peak damage phase. Furthermore HuRIEC mice 
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show more than 60% attenuation in the polyposis phenotype in the Apcmin/+ mice 
(Giammanco et al. 2014).By contrast, HuRIEC mice show increased protection in the 
AOM-DSS model of tumorigenesis (Giammanco et al. 2014). In intestinal cell lines, HUR 
inhibition causes a significant decrease in Wnt signaling, thereby suggesting a potential 
role in the regulation of the Wnt pathway (Liu et al. 2014a). HuR also has tumor 
suppressive functions via the regulation of tumor suppressors p21 and Wnt family 
protein Wnt-5a (Leandersson et al. 2006). HuR is known to mediate post-transcriptional 
regulation of its target mRNAs and is critical for neoplastic transformation and cancer 
development. Furthermore, HuR is activated in response to various stressors(Brody and 
Dixon 2018). HuR is being explored as a therapeutic target and small molecule inhibitors 
are being developed (Brody and Gonye 2011; Blanco et al. 2016; Brody and Dixon 
2018).One such molecule , MS-444, has been shown to inhibit HuR that in turn 
decreases GI tumorigenesis and the proliferation of colon cancer cells (Blanco et al. 
2016; Lang et al. 2017).  
 
Mex3A 
In humans, MEX3 has 4 homologous isoforms MEX 3A-3D(Buchet-Poyau et al. 
2007). In mice, MEX3A is expressed in the crypt base and labels a slowly cycling 
subpopulation of Lgr5+ intestinal stem cell population that can give rise to all lineages 
(Barriga et al. 2017). These MEX3A- high cells appear to resist the deleterious effects of 
chemotherapy or irradiation and play an important role in regeneration of damaged 
crypts(Barriga et al. 2017). Previous studies have shown that MEX3A regulates CDX2 in 
human colon cancer and correlates with “stemness” (Pereira et al. 2013). Mex3a 
deletion in IEC does not cause any changes in reproduction and intestinal morphology in 
mice (Barriga et al. 2017). In Caco2 cells that can spontaneously differentiate into an 
enterocytic-like phenotype upon reaching confluence (Pinto et al. 1983), inhibition of 
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endogenous MEX3A using siRNA resulted in higher CDX2 expression (Pereira et al. 
2013). MEX3A overexpressing Caco2 cells show increased RNA expression of stem cell 
markers (Pereira et al. 2013). Mex3a is overexpressed in cancers like bladder urothelial 
carcinoma  (Sakurai et al. 2017) and Wilm’s tumor (Jiang et al. 2012) whereas 
knockdown of MEX3A in human gastric cancer cells has been shown to significantly 
reduce cell proliferation (Jiang et al. 2012) thus indicating its role in carcinogenesis and 




CUG binding protein 1 (CUBP1) or CELF1 is a multifunctional RBP studied 
primarily for its role in RNA metabolism related processes like decay, translation and 
splicing. CELF1 is known to bind GU rich elements in 3’UTR of target RNAs to regulate 
RNA stability (Vlasova-St Louis and Bohjanen 2011). In mice, CELF1 is expressed 
throughout the small intestinal epithelium (Liu et al. 2015) and can be repressed by mir-
503 and recruited to P bodies (Cui et al. 2012). mRNAs are localized to these 
cytoplasmic RNP foci and sorted for degradation and/or translational repression. CELF1 
is also known to recruit certain target mRNAs like occludin to these P bodies and 
partially repress their translation (Liu et al. 2015).  Although CELF1 expression is found 
to increase proliferation and progression of several cancers (House et al. 2015; Xia et al. 
2015; Cifdaloz et al. 2017), increased CELF1 causes G1 phase growth arrest in 
intestinal epithelial cells. By contrast, CELF1 silencing enhances cell proliferation, with 
an increase in cells residing in S-phase, and elevated cell number. CELF1 silencing 
enhances MYC translation by releasing MYC RNA from RNP complexes (Liu et al. 
2015). HUR is found to competitively repress this CELF1-MYC interaction (Liu et al. 
2015). CELF1 is mainly studied for its role in regulation of splicing in myotonic dystrophy 
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(Ho et al. 2005; Zhang et al. 2008). In the context of cancer, CELF1 can act as a tumor 
suppressor (in liver cancer (Lewis et al. 2017)) , increase caspase activity/apoptosis (in 
hepatocellular carcinoma(Kim et al. 2017b) and  esophageal cancer (Chang et al. 2012)) 
and act as a central node in post-transcriptional regulatory programs underlying EMT (in 
breast cancer (Chaudhury et al. 2016)) indicating its diverse role in carcinogenesis. 
 
RBM3 
RNA-binding motif protein 3 (RBM3) , a glycine rich RBP (Kishore et al. 2010), is 
an important cold shock protein that is upregulated during environmental stimuli such as 
hypothermia, ischemia, and hypoxia (Yang et al. 2014). RBM3 deficient mice show no 
overt phenotype or growth changes and are fertile (Matsuda et al. 2011). RBM3 
overexpression in HCT116 and DLD1 colon cancer cells increases proliferation and 
engenders chemotherapy resistance. These cells also exhibit increased stem cell 
markers via an increase in Β-CATENIN activity. Therefore, the Β-CATENIN signaling 
pathway may be regulated through alterations in expression of RBM3 (Venugopal et al. 
2016). In colon cancer, RBM3 is upregulated in a stage dependent manner and its 
overexpression is capable of inducing oncogenic transformation (Sureban et al. 2008). 
RBM3 is shown to increase the stability and translation of rapidly degraded mRNAs such 
as cyclooxygenase 2 (COX-2), interleukin-8 (IL-8), and vascular endothelial growth 
factor (VEGF) (Sureban et al. 2008). Like the other RBPs, the role of RBM3 can be 
dichotomous in different contexts. In breast cancer, higher RBM3 expression correlates 
with increased disease-free survival (Jogi et al. 2009). RBM3 expression is upregulated 
in, and correlates with, good prognosis in several cancers, including ovarian, prostate, 
bladder, gastric, and colorectal cancer (Grupp et al. 2014; Melling et al. 2016; Jang et al. 
2017; Ye et al. 2017). RBM3 causes cellular differentiation and apoptosis in these 
cancers.  
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Dichotomous roles of RBPs in gastrointestinal cancer 
 RBPs are rapid and effective regulators since they bind already transcribed 
targets. The functional role of RBPs therefore depend on the transcripts present within a 
specific cell type. Even in the same cell type, changes in the transcriptome, due to 
environmental changes or injury, can lead to different functional outcomes for RBPs. 
This is also true for different tissues or organs where transcriptome profiles vary. 
Furthermore, since RBPs binding to target transcripts can result in a number of 
functional outcomes, it may be difficult to extrapolate the functional role from one context 
to another. For example, although IMP1 is recognized as an oncofetal protein due to its 
over-expression in colorectal cancers and increased tumor burden with IMP1 expression 
in xenograft models(Hamilton et al. 2013), IMP1 deletion in mesenchymal cells in the 
intestinal mucosa leads to increased tumor burden in mice(Hamilton et al. 2015). Similar, 
opposing roles for IMP1 has also been reported in breast cancer (Nwokafor et al. 2016) 
(Wang et al. 2016a) (Tessier et al. 2004). IMP may therefore can exhibit both tumor-
initiating or tumor suppressive functions. Another example of this paradigm is HuR, 
which has been known to stabilize and increase translation of several key cancer related 
pathways(Mazan-Mamczarz et al. 2008). In a recent study in pancreatic ductal 
adenocarcinoma cells, HuR deletion resulted in a decrease in proliferation and an 
increase in cell death, possibly via regulation of KRAS pathway genes(Lal et al. 2017). In 
contrast, other studies have shown that HuR knockdown in myeloid lineage cells in mice 
caused an increased susceptibility to colitis associated cancer and increase in 
inflammatory mRNAs(Yiakouvaki et al. 2012).  
Similarly, while CELF1 deletion in several cancer cell lines decreased 
proliferation and migration(Gao et al. 2015; House et al. 2015), and Celf1-deficient mice 
exhibited growth retardation(Kress et al. 2007), it has also been reported to promote 
apoptotic resistance in esophageal cancer(Chang et al. 2012). Furthermore, CELF1 
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exhibits opposing effects on cell proliferation in primary versus malignant T cells due to 
differences in the transcriptomes (Bohjanen et al. 2015).  In yet another example, Mex3a 
is expressed in slow dividing intestinal stem cells(Barriga et al. 2017), but in CRC cell 
lines, the effect of MEX3A on differentiation depends on cell confluence. At low 
confluency, MEX3A inhibition increased CDX2 expression, but this effect was reverted 
when the cells were highly confluent(Pereira et al. 2013). Taken together, these studies 
demonstrate that RBPs represent a complex regulatory network and their functional 
roles depend on the tissue type, microenvironment and the transcriptome of cells in 
which they are expressed. Therefore, understanding the precise, context-dependent 
mechanisms by which RBPs regulate protein expression in combination with other 
factors will be essential to understanding their complex roles in gastrointestinal cancers. 
Identifying binding targets of RBPs 
Crosslinking Immunoprecipitation – Sequencing (CLIP-Seq) 
 There are multiple experimental methods to unravel the landscape of RBP 
biology and their roles in disease (Figure 4). One method for identifying direct roles of 
RNA binding proteins has been to determine their target transcripts, using crosslinking 
immunoprecipitation (CLIP). The RBP under study is crosslinked in vivo to its target 
transcripts via a crosslinking agent, such as UV light, that forms covalent bonds between 
the RNA and protein. Cells are then lysed and the RBP precipitated using an antibody. 
Proteinase K is used to digest the RBP and leave the bound transcripts intact. After 
ligating adapters and linkers to the RNA, the transcript is reverse transcribed to cDNA 
and identified via high-throughput sequencing(Ule et al. 2003). CLIP techniques have 
been refined over the years to increase precision and sensitivity.  
Several high precision crosslinking immunoprecipitation (CLIP) techniques in 
conjunction with sequencing have been developed, including HITS-CLIP(high-
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throughput sequencing of RNA isolated by crosslinking immunoprecipitation)(Darnell 
2010), PAR-CLIP(photoactivatable ribonucleoside–enhanced cross-linking and 
immunoprecipitation) (Hafner et al. 2010) and iCLIP (individual nucleotide–resolution 
cross-linking and immunoprecipitation) (Konig et al. 2010), among others. These can 
provide single nucleotide level resolution in vivo. These protocols can be technically 
challenging, with complex library preparations and difficulty in identifying targets when 
binding domains are not clearly understood. Newly improved eCLIP protocols have 
overcome some of these challenges(Van Nostrand et al. 2016). Although CLIP protocols 
can induce mutations due to UV-crosslinking and resulting in reduced sensitivity, it can 
be overcome by using PAR-CLIP techniques that incorporate photoactivatable 
ribonucleoside analogs into nascent transcripts as a means to decrease background 
noise(Ascano et al. 2012). A comparison between these techniques are listed in Table 1 
(adapted from (Wang et al. 2015b)).  
CLIP- Seq libraries have been generated for several RBPs in different cell types, 
including LIN28B(Madison et al. 2013b), IMP1(Conway et al. 2016) and MSI1(Bennett et 
al. 2016). While CLIP studies have been essential in our understanding of basic RBP 
biology, there are limitations. For example, several RBPs are only expressed in 
undifferentiated cells and their expression is very low in differentiated intestinal cells and 
therefore CLIP studies become a challenge unless the RBPs are genetically 
overexpressed or induced during stress or disease models. Although these analyses are 
feasible, the presence of non-physiological levels of these RBPs with several RNA 
binding sites may promote non-specific interactions or false positive binding targets. 
Furthermore, depending on the cell lines or tissues used, the transcriptome varies and 
thus the context-specificity of strength and intensity of binding may not be recapitulated.  
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RNA-Sequencing: evaluating the transcriptome in cells with over-expression or deletion 
of RBPs 
Another technique to study the role of RBPs is to evaluate the transcriptome after 
modulation of RBP expression. This has been especially useful in genome wide 
association studies for human cancers. Whole genome RNA sequencing has been used 
to generate libraries for several cancers to identify genes that are amplified or silenced 
at transcription level(Lee et al. 2015). These libraries have been made publicly available 
using the Cancer Genome Atlas (TCGA) databases(Tomczak et al. 2015). RNA levels 
can be used along with DNA sequencing and clinical data for a variety of association 
studies to identify potential therapeutic targets. These targets can then be studied 
functionally to understand their roles.  TCGA uses an Illumina based RNA sequencing 
platform and helps identify and quantify rare and common transcripts, isoforms, novel 
transcripts, gene fusions, and non-coding RNAs, among a wide range of samples, 
including low-quality samples(Wang et al. 2009). Transcriptome analysis provides 
information on RNA sequence coverage, sequence variants (e.g. fusion genes), 
expression of genes, exon, or junction. This can further be correlated to somatic 
mutation status, disease stage, prognosis and other clinical data(Brody and Dixon 2018). 
Functional effects of RBPs can be studied by overexpressing or deleting the RBP 
gene followed by high-throughput RNA sequencing. This generates a snapshot of total 
RNA abundance in the presence or absence of a given RBP. Since RBPs can regulate 
the stabilization, degradation, localization and post-transcriptional modification (for 
example, splicing) of their targets, RNA sequencing provides a robust tool to study these 
changes in an unbiased, genomic way. However, since proteins are the functional 
effectors in cells, RNA sequencing may not serve as a direct indication of the functional 
role of the RBP. For example, some RBPs may bind to their target transcripts and cage 
them in RNP granules, making them inaccessible to the translation machinery(Bley et al. 
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2015). In these cases, mRNA abundance does not correlate to translation/functional 
effects. Therefore, RNA sequencing should be combined with additional analyses to 
determine functional roles of RBPs. 
 
Ribosome profiling: Studying the ‘translatome’  
 To completely understand the functional effect of RBP expression or deletion, 
evaluation of the protein landscape is required.  Proteomics encompasses the study of 
the function and structure of proteins in a complex biological sample. Mass 
spectrometry(Whitelegge et al. 1999) and Edman degradation(Edman and Begg 1967) 
remain the two major techniques used for protein sequencing or to identify post-
translational modifications. There are several challenges with these techniques including 
technical challenges (such as protein solubility, separation, detection of intact proteins), 
scalability, difficulty in sample preparation, high expense, low sensitivity and limitations 
in bioinformatics tools(Chandramouli and Qian 2009; Gregorich and Ge 2014). In recent 
years, ribosome footprint profiling (RFP) has been developed as a powerful tool to obtain 
a global snapshot of actively translating transcripts within a cell(Ingolia et al. 2013; 
Ingolia et al. 2014; Ingolia 2016).   
This ribosome-centric technique uses binding and density of ribosomes on a 
transcript as an indicator of active translation. Profiling is done by deep sequencing of 
ribosome bound transcripts as well as sequencing total RNA abundance. Polysomes (a 
cluster of ribosomes held together by a strand of messenger RNA that each ribosome is 
translating) are stabilized by blocking translation elongation using cyclohexamide before 
cell lysis(Ingolia et al. 2011).  This technique detects relative changes, so it relies on 
cells or tissues with deletion or overexpression of the desired RBP.  This technique can 
help distinguish between genes regulated at the transcriptome and translatome levels. 
The ratio of RFP to total mRNA abundance for each transcript reveals the translation 
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efficiency for that gene that can be compared across genotypes or conditions(Zhou et al. 
2013a) (Figure 5).  
 
Incorporating multiple techniques to understand the global function 
 To completely understand the function of a RBP in a cell, we need to understand 
what target transcripts it binds to, the context-dependent binding, and downstream effect 
on transcription and translation of the transcript. To that end, combining CLIP-seq with 
ribosome profiling or proteomics would provide a more complete functional snapshot for 
a given RBP. Furthermore, genetic engineering studies can be used to overexpress or 
delete the RBP in different cell types at homeostasis and injury conditions to further 
increase our understanding of the dynamic role of RBPs in vivo. In conclusion, we have 
discussed a number of GI-relevant RBPs and their roles in homeostasis and disease. 
Furthermore, we highlight emerging techniques that may be employed in vivo to 
understand the context (cell type and disease state)-dependent function of RBPs. 
Identifying mechanisms of RBP biology in GI diseases may provide a foundation for new 
therapies to target or modulate RBP-RNA interactions. 
The LIN28B - IMP1 axis – The hypothesis 
The intestinal epithelium is in a dynamic equilibrium of proliferation, differentiation and 
apoptosis along the crypt-villus gradient. Normal intestinal homeostasis is disturbed 
during states of infection, inflammation and malignant transformation (adenomatous 
polyps, colorectal cancer). The pathogenesis of sporadic colorectal cancer (CRC) 
involves distinct pathways with characteristic genomic and genetic alterations. Despite 
significant advances in leveraging our understanding of these pathways for diagnostic, 
prognostic, and therapeutic strategies, colorectal cancer remains a top cause of cancer-
related mortality, resulting in greater 
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than 50,000 deaths per year in the United States. This underscores a specific need to 
identify and understand novel, therapeutically tractable pathways in intestinal 
homeostasis that may drive CRC. Our work has introduced and elucidated the role of 
mRNA binding proteins in intestinal/colonic epithelial homeostasis, as well as 
aberrations including hyperproliferation, altered metabolism and transformation (1-6). 
Regulation of cellular identity and behavior via RNA binding proteins represent a unique 
layer of signaling control, where individual RNA binding proteins or networks represent 
the novel paradigm of “RNA regulons” (7). My thesis seeks to parse the individual and 
cooperative roles of two essential RNA binding proteins, LIN28B and IMP1, in 
gastrointestinal homeostasis and disease. 
 
LIN28B plays a functional role in embryonic stem cells (ESCs) and induced pluripotent 
stem cells (iPSCs), where Oct4, Sox2, and Nanog occupy its promoter (8). LIN28B binds 
to and promotes the translation of multiple mRNA targets, including IGF2, OCT4, 
CCNB1, and BMP4 (9-11). In addition to regulating mRNAs, LIN28B post-
transcriptionally regulates the Let-7 microRNA family via binding to pri-Let-7 in the 
nucleus, where it prevents Drosha-mediated cleavage and maturation resulting in 
suppression of differentiation (12). Let-7 
microRNAs have diverse mRNA targets, including IMP1 (Igf2 mRNA binding protein-1), 
another mRNA binding protein with diverse functional roles. IMP1 binds to and promotes 
the translation of several mRNAs, including MYC, ACTB, and IGF2 mRNAs (13-16). 
Mice with global Imp1 gene deletion exhibit dwarfism and decreased survival, 
suggesting a critical role for Imp1 in development (17). Taken together, the LIN28B/Let-
7/IMP1 axis represents a powerful signaling node with broad, yet incompletely 
understood functional roles. Furthermore, despite their association via Let-7, the 
overlapping and divergent targets of LIN28B and IMP1 have yet to be determined and 
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functionally characterized. Mechanistically, LIN28B and IMP1 have been associated with 
translation (via localization in polysomes) and mRNA localization (based upon 
localization in RNA particles and RNA granules), respectively (18). Subcellular 
localization of RNA binding proteins and their respective mRNA targets indicate that a 
subset of transcripts may be protected from degradation or repressed (rather than 
actively translated), the basis of which is not known for LIN28B and IMP1. As such, 
strategies to understand the effects of LIN28B and IMP1 on both transcript and protein 
abundance are highly relevant. 
We have demonstrated that LIN28B drives tumor-initiating cell phenotype 
however, it remains unclear if LIN28B-mediated hyperproliferation, altered differentiation, 
and associated tumorigenesis is functionally dependent on IMP1. In addition, it remains 
unknown if the roles of IMP1 depend entirely on its regulation by Let-7 downstream of 
LIN28B. Taken together, published data from our own and other laboratories support the 
scientific premise that LIN28B and IMP1 represent functionally interdependent signaling 
modulators that may play critical roles in normal intestinal homeostasis and disease. The 
current Aims will address the hypothesis that LIN28B and IMP1 comprise cooperative 
roles in controlling post-transcriptionally the pathways associated with epithelial cell fate, 
which may favor malignant 
transformation.  
Studies herein will reveal new insights into how synergy within the LIN28B-Let-7-IMP1 
axis 
modulates intestinal epithelial homeostasis and cancer and will identify the specific 
mechanistic underpinnings. These findings have the potential to introduce a new 
paradigm of dose-dependent roles for mRNA binding proteins within the same axis as 
new prognostic indicators. In addition, the LIN28B-Let-7-IMP1 axis has emerged recently 
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as a novel therapeutic target for RNA-based therapies, which could be directly 




Figures and figure legends 
Figure 1: Schematic representation of the crypt-villus axis and the major intestinal 
cell types for small intestine and colon 
 
The figure depicts the major cell types in the small intestine and colon. The stem cells 
reside at the crypt base and proliferate (transit amplifying cells) and differentiate into 
secretory (Paneth, enteroendocrine, goblet, tufts cells) and absorptive lineages 





Figure 2: Schematic representation of the different functional roles of RBPs 
 
The figure depicts the major functional roles of the RBPs discussed in this chapter. The 
majority of the RBPs discussed here bind to mRNAs and regulate their processing (5’ 
capping, 3’ end processing, splicing), stability, localization and translation. This figure 











The figure shows a simplistic representation of the different structural domains of the 
RBPs that help them bind to their target RNAs and regulate their function. The amino 
acid length of the RBPs are also indicated. The RBPs contain different types of RNA 
binding and catalytic domains including RRMs, KH domains, zinc finger domains and 
cold shock domains. LIN28 proteins also contain localization signals to help them shuttle 




Figure 4: Different experimental methods to unravel the landscape of RBP biology 





Figure 5: Schematic representation of Ribosome profiling 
 
 
Ribosome profiling produces a “global snapshot” of all the ribosomes active in a cell at a 
particular moment, known as a translatome.  It enables researchers to identify the 
location of translation start sites, the complement of translated ORFs in a cell or tissue, 
the distribution of ribosomes on a messenger RNA, and the speed of translating 
ribosomes. Ribosome profiling involves similar sequencing library preparation and data 
analysis to RNA-Seq, but unlike RNA-Seq, which sequences all of the mRNA of a given 
sequence present in a sample, ribosome profiling targets only mRNA sequences 













CHAPTER II:  THE LIN28B-IMP1 POST-
TRANSCRIPTIONAL REGULON HAS OPPOSING 
EFFECTS ON ONCOGENIC SIGNALING IN THE 
INTESTINE 
(This section has been accepted for publication at Genes and Development 




RNA binding proteins (RBPs) are expressed broadly during both development and 
malignant transformation, yet their mechanistic roles in epithelial homeostasis or as 
drivers of tumor initiation and progression are incompletely understood. Here we 
describe a novel interplay between RBPs LIN28B and IMP1 in intestinal epithelial cells. 
Ribosome-profiling and RNA-sequencing identifies IMP1 as a principle node for gene 
expression regulation downstream of LIN28B. In vitro and in vivo data demonstrate that 
epithelial IMP1 loss increases expression of WNT target genes and enhances LIN28B-
mediated intestinal tumorigenesis, which was reversed when we overexpressed IMP1 
independently in vivo. Together, the data provides new evidence for the opposing effects 
of the LIN28B-IMP1 axis on post-transcriptional regulation of canonical WNT signaling, 
with implications in intestinal homeostasis, regeneration and tumorigenesis.  
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Post-transcriptional regulation of key growth and oncogenic pathways by RNA 
binding proteins (RBPs) is an emerging hallmark of cancer. Understanding the relative 
contribution and regulation of gene transcription and translation to functional and 
phenotypic outcomes is essential for generating effective therapeutics. Given the large 
number of putative binding targets and effector pathways downstream of RBPs, their 
evaluation in vivo is critical to understanding the prevailing effects of specific RBP:RNA 
target interactions in variable biological contexts. Intestinal epithelial cells exhibit 
remarkable plasticity in their ability to rapidly proliferate, differentiate, and undergo 
repair- processes that are aberrantly regulated during tumorigenesis. While the critical 
cellular pathways for epithelial injury repair and tumor development are well studied, the 
relative contribution of RBPs as key, functional regulators of these pathways are just 
beginning to be understood. A primary role of RBPs is to bind to and regulate 
functionally interrelated target transcripts, forming functional units referred to as 
“regulons" (Keene 2007; Morris et al. 2010). The integration of transcriptional and 
translational data has revealed that a significant number of genes are highly regulated at 
the translational level, underscoring the potential significant contribution of RBPs to 
numerous basic biological functions (Schafer et al. 2015). Pathways critical to epithelial 
homeostasis, such as WNT signaling, are aberrantly activated in and can contribute to 
colorectal cancer (CRC) pathogenesis, resulting in challenges for direct therapeutic 
targeting.  
As a master regulator of the let-7 family of microRNAs, LIN28B exerts its effects 
via suppression of let-7 processing and thus up-regulation of let-7 targets, including 
HMGA2 and IGF2BP1 (IMP1) (Boyerinas et al. 2008; Piskounova et al. 2011). In 
addition, LIN28B acts as a pluripotency factor and promotes tumorigenesis in multiple 
tissues (Viswanathan et al. 2009; Tu et al. 2015; Rahkonen et al. 2016; Zhang et al. 
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2016). We demonstrated previously that LIN28B overexpression promotes migration and 
invasion in vitro and that CRC cells overexpressing LIN28B exhibit smaller, yet more 
metastatic tumors in subcutaneous xenograft mouse models. (King et al. 2011a; King et 
al. 2011b). In addition, we and others have established LIN28B is a bone fide oncogene 
in the intestinal epithelium (Madison et al. 2013b); (Tu et al. 2015).  Furthermore, 
tumorigenesis was accelerated in mice with specific deletion of let-7c2/let-7b, suggesting 
that the oncogenic effects of LIN28B are predominantly via its regulation of let-7. In 
support of this notion, deletion of a single allele of the let-7 target Hmga2 repressed 
Lin28b-driven tumorigenesis (Madison et al. 2015). Other key let-7 targets upregulated 
in VillinLin28b mice included Igf2bp1, Igf2bp2, E2f5, cyclinD1 and Acvr1c. Recognizing 
that LIN28B functions as an oncogene in CRC and blocks processing of pre/pri -let-7, we 
reasoned that let-7 mRNA targets may be effectors of LIN28B-mediated oncogenic 
transformation.  Specifically, we hypothesized that IMP1 may be a critical effector of 
LIN28B’s actions.   
 IMP1 is a RBP with oncofetal functions that is minimally expressed in adult 
tissues during homeostasis. We demonstrated previously in subcutaneous xenografts 
that IMP1 overexpression in SW480 CRC cells exhibit increased tumor volume and 
elevated levels of its mRNA-binding target CD44 (Hamilton et al. 2013). Conversely, loss 
of both Imp1 alleles in stromal cells led to enhanced tumor load in colitis-associated 
colon tumorigenesis (Hamilton et al. 2015) indicating a tumor-suppressive role for IMP1 
in this context. Others have reported diverse findings in other cancers; for example, 
overexpression of the IMP1 mouse homolog CRD-BP in mammary epithelial cells 
resulted in mammary tumor formation with a subset of mice exhibiting metastasis 
(Tessier et al. 2004). Conversely, studies in orthotopic breast fat pad xenografts 
demonstrated that IMP1 overexpression suppressed the growth of MDA231 cell-derived 
tumors and subsequent lung metastasis, as well as an associated decrease in IMP1 
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mRNA-binding targets PTGS2, GDF15, and IGF2 (Wang et al. 2016a). Finally, ectopic 
Imp1 expression in the MMTV-PyMT breast cancer mouse model significantly reduced 
metastatic tumors (Nwokafor et al. 2016). Based upon these functional studies, we 
conclude that IMP1 may exhibit oncogenic or tumor suppressive functions in a context-
dependent manner. Furthermore, these studies demonstrate that IMP1 may enhance or 
suppress its mRNA-binding targets.  
In the current study, we utilize the intestinal epithelium as a prototypical model for 
understanding the tissue-specific roles of two key RBPs, LIN28B and IMP1, in the 
context of fundamental homeostasis and tumorigenesis. We performed novel and 
unbiased transcriptome and translatome studies as a function of LIN28B expression and 
found that IMP1 is a top regulator of differentially expressed transcripts with LIN28B 
overexpression. We next evaluated the in vivo consequences of LIN28B expression with 
and without IMP1 expression, elucidating their functional relevance in intestinal 
homeostasis and tumorigenesis with pivotal involvement of WNT signaling. Taken 
together, our studies reveal a LIN28B-IMP1 axis governing a post-transcriptional regulon 
capable of modulating epithelial cell growth via global control of the WNT pathway. 
Results 
IMP1 loss is a significant regulator of translation in the context of LIN28B 
overexpression 
To understand how LIN28B may modulate translation of the transcriptome, and 
how this is impacted by IMP1, we used ribosome profiling to obtain a genome-wide 
snapshot of translation in the context of LIN28B overexpression. First, we evaluated 
SW480 CRC cells overexpressing LIN28B (King et al. 2011a; King et al. 2011b) 
(Supplemental Figure 1A). We used tRanslatome (Tebaldi et al. 2014) to identify 
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putative regulatory factors upstream of differentially translated genes in LIN28B 
overexpressing versus control cells. This method computes a Fisher test p-value 
indicating whether binding sites for each regulator are significantly enriched in 
differentially expressed genes lists. This analysis allows the user to identify possible 
regulatory factors responsible for the translational regulation of differentially expressed 
genes in the experiment under consideration. The list of genes regulated by each post-
transcriptional element was obtained from the Atlas of UTR Regulatory Activity (AURA) 
database (Dassi et al. 2014). Through this analysis, we identified IMP1 as a significant 
post-transcriptional regulator in LIN28B overexpressing cells (Figure 6A).  
Next, we analyzed differential gene expression between LIN28B overexpressing 
lines with and without CRISPR/Cas9-mediated IMP1 deletion (Supplemental Figure 1A) 
and calculated log fold-changes between ribosome-bound RNAs (ribosome protected 
fragments, RPF) and total mRNA. A total of 1284 genes were regulated by IMP1 
exclusively at the translational level, whereas 264 genes were regulated only at the 
transcriptional level.  Additionally, 458 genes were regulated via translational 
antagonism, where genes exhibited increased mRNA levels, but lower translational 
efficiencies or vice versa, or translational reinforcement –where translational changes 
amplified the changes at the mRNA level (Figure 6B). These data demonstrate IMP1 is a 
major translational regulator of target genes. Translational regulation can occur through 
differential translation efficiencies (TE) of transcripts, which is calculated as the ratio of 
RPF reads to total mRNA abundance. We observed several transcripts with significantly 
different TE values between cells overexpressing LIN28B with or without IMP1 deletion 
(Figure 6C). Pathway enrichment analysis for TE genes differentially expressed in 
LIN28B cells with or without IMP1 deletion revealed a significant representation of 
pathways linked to cancer, including the WNT signaling pathway (Figure 6D, 
Supplemental Table 3). Finally, gene-set enrichment analysis (GSEA) of RNA-seq data 
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from the same cells suggest that IMP1 deletion upregulates WNT signaling at the mRNA 
level as well (Supplemental Table 1), demonstrating IMP1 modulation of WNT at both 
transcript abundance/stability and TE levels in this context. We further validated this in 
the SW480 cells overexpressing LIN28B with and without IMP1 deletion (Supplemental 
Figure 1C,D). We saw a significant upregulation of Wnt targets with IMP1 deletion via 
qPCR and upregulation of ß-catenin protein levels via western blot in these cells. Finally, 
to validate upregulation of Wnt targets identified via RNA sequencing, we used siRNA to 
knockdown IMP1 in Caco2 cells (Supplementary Figure 4A,B) that endogenously 
express LIN28B (Mizuno et al. 2018). We observed significant upregulation of multiple 
WNT targets with IMP1 knockdown, corroborating our findings in a second, independent 
cell line (Supplemental Figure 4A,B). 
In an attempt to elucidate if direct binding may correlate with TE, we compared 
binding intensities of IMP1 targets identified via previously published enhanced UV 
crosslinking and immunoprecipitation (eCLIP) in human pluripotent stem cells (hPSCs) 
(Conway et al. 2016) with differential translational efficiency (TE) of these targets from 
the present study (in human CRC cells). However, we found no correlation between 
binding intensities and TEs (Supplemental Figure 1B). In addition, a large number of 
targets identified in eCLIP studies did not change significantly in our TE dataset and vice 
versa (Supplemental Table 2). While we cannot exclude the possibility that differences 
between mRNA-binding and TEs may be due in part to comparing hPSCs to CRC cells, 
these data nevertheless reinforce the concept that eCLIP-identified IMP1-bound targets 
may not necessarily correlate with gene expression changes (Conway et al. 2016).  
 
IMP1 loss enhances LIN28B-mediated tumorigenesis in vivo 
Gene expression and ribosome profiling data suggest that IMP1 loss causes 
dysregulation of several key signaling pathways that are involved in cellular proliferation 
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and maintenance. To understand the phenotypic consequence of these changes, we 
used LIN28B-overexpressing CRC cells with and without IMP1 loss in subcutaneous 
xenograft experiments (Supplemental Figure 2A). Consistent with our prior published 
studies, LIN28B overexpression caused a significant decrease in tumor volume as 
compared to controls, irrespective of IMP1 status (Supplemental Figure 2B) (King et al. 
2011a). LIN28B overexpressing tumors exhibited a more differentiated phenotype as 
compared to controls, which had poorly differentiated tumors. This differentiation 
phenotype was reversed with IMP1 loss in LIN28B overexpressing cells (Supplemental 
Figure 2C), suggesting that IMP1 loss may promote an in increased stemness markers 
and/or downregulate differentiation pathways in CRC cells. We also observed an 
upregulation of nuclear ß-catenin staining with IMP1 loss and a significant increase in 
Wnt signature in these tumors (Supplemental Figure 2C,D). 
To confirm that LIN28B expression in transformed cells can promote 
differentiation, we evaluated LIN28B expression and differentiation status in human 
colon tumors in colon cancer tissue microarrays(King et al. 2011a). We found that the 
majority of LIN28B overexpressing tumors were either moderately or well differentiated 
(Supplementary Figure 2E). The mechanistic explanation for this is not known; however, 
recent studies have demonstrated that in some CRC cell lines, overexpression of 
pluripotency factors (OCT3/4, SOX2 and KLF4) can lead to tumors with increased 
differentiation(Oshima et al. 2014). This is in line with our finding, since LIN28B is also a 
pluripotency factor (Rahkonen et al. 2016; Zhang et al. 2016; Tsanov et al. 2017), 
although this does not mean that pluripotency and differentiation are necessarily linked 
in this context.  
We next evaluated transgenic mice with intestinal epithelial overexpression of 
Lin28b (Villin-Lin28b) and intestinal epithelial-specific deletion of Imp1 (VillinCre; Imp1fl/fl) 
(Hamilton et al. 2013; Madison et al. 2013b) (Supplemental Figure 2F). Our prior work 
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demonstrated de novo intestinal tumor growth in Villin-Lin28b mice, confirming that 
Lin28b can act as an oncogene in the intestine (Madison et al. 2013b). Imp1 expression 
is enhanced significantly in Villin-Lin28b mice and completely eliminated in the intestinal 
epithelium of Villin-Lin28b; VillinCre;Imp1fl/fl mice (Figure 7A). We found that at 12 
months of age, 18/25 Villin-Lin28b mice (72%) had at least one tumor, while 10/12 
(83.33%) of Villin-Lin28b; VillinCre;Imp1fl/fl mice had tumors, the majority of which had 
multiple lesions. Aged mice overexpressing LIN28B exhibit a significant increase in 
number of proliferating cells (Figure 7B,C) in normal tissue. Villin-Lin28b; 
VillinCre;Imp1fl/fl mice exhibit a significant increase in intestinal tumor number/mouse 
compared to Villin-Lin28b mice (Figure 7D). We did not observe hyperplasia or tumor 
growth with Imp1 loss alone, evaluated out to 12 months of age. Histological grading 
revealed a higher percentage of adenocarcinoma lesions in Villin-
Lin28b;VillinCre;Imp1fl/fl compared to Villin-Lin28b mice (Figure 7E,F), demonstrating 
that Imp1 loss promotes higher tumor number and grade in the context of Lin28b 
overexpression.  
 Our prior studies demonstrated that Lin28b overexpression results in increased 
expression of other let-7 targets, including Hmga2, Arid3a, Igf2bp2, and CycD1, as well 
as enhanced expression of stem cell-related genes (Madison et al. 2015). We evaluated 
isolated epithelia from aged mice and found no significant change in Arid3a, Igf2bp2, 
Hmga2 and CycD1 expression in Villin-Lin28b;VillinCre;Imp1fl/fl mice compared to Villin-
Lin28b mice (Figure 7G). We found a robust increase in stem cell and broader crypt cell 
markers including Prom1, Hopx, Bmi1, Lgr5, and Olfm4 (van der Flier et al. 2009; Zhu et 
al. 2009; Takeda et al. 2011; Tian et al. 2011; de Sousa e Melo et al. 2017), suggesting 
an expansion of the stem cell compartment in Villin-Lin28b;VillinCre;Imp1fl/fl compared to 
Villin-Lin28b mice (Figure 7H). Consistent with an expansion of the crypt base stem cell 
compartment, we observed an increase in WNT target gene expression with Imp1 loss, 
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both at the mRNA and protein levels (Figure 7I-K and Supplementary Figure 3D). This 
effect was also observed ex vivo in enteroids generated from isolated crypts, where 
Villin-Lin28b;VillinCre;Imp1fl/fl enteroids exhibit increased AXIN2 expression compared to 
wildtype or Villin-Lin28b mouse enteroids (Supplementary Figure 2G). Together, these 
data support the hypothesis that IMP1 may modulate stem cell signature and canonical 
WNT target gene expression in the intestine and that these effects persist in isolated 
crypt enteroid cultures. 
 To understand these findings in the context of patients with CRC, we evaluated 
the Cancer Genome Atlas (Cline et al. 2013) for LIN28B and IMP1 expression levels in 
colon and rectal adenocarcinoma patients (COADREAD). We found a positive 
correlation between the two transcripts in patient tumors (Pearson’s coefficient=0.266, 
p<0.0001; Supplemental Figure 3A). However, tumor stage-wise evaluation revealed 
higher IMP1 expression in all tumor stages, whereas LIN28B expression increased in 
Stage IV, supporting the concept that IMP1 expression is regulated via additional 
mechanisms beyond LIN28B (Supplemental Figure 3B). 
 
IMP1 regulates intestinal epithelial regeneration 
Building upon our observation that Imp1 loss upregulates stem cell and WNT 
target genes in the context of LIN28B overexpression, we sought to understand broader 
roles for IMP1 in the context of intestinal homeostasis and injury repair. Radiation injury 
has been increasingly used to study stem cell function and regeneration of the intestinal 
epithelium (Potten 2004; Zhou et al. 2013b; Gregorieff et al. 2015). Imp1 expression is 
low in the adult intestinal crypt but is increased in regenerating epithelium following 
whole body irradiation (Figure 8A). We observed IMP1 protein expression specifically in 
regenerative foci 4 days following irradiation, a time point where surviving stem cells are 
undergoing rapid proliferation to replenish the epithelium and restore barrier function 
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(Figure 8B). We observed that Villin-Lin28b mice lose significantly more weight at day 4 
post-irradiation as compared to wildtype controls. This phenotype is reversed in Villin-
Lin28b;VillinCre;Imp1fl/fl mice, where Imp1 deletion results in significantly less weight loss 
as compared to Villin-Lin28b mice, returning to wildtype levels (Figure 8C). Furthermore, 
the number of regenerative crypts at day 4 following radiation is significantly higher in 
Villin-Lin28b;VillinCre;Imp1fl/fl mice compared to Villin-Lin28b mice (Figure 8D). Villin-
Lin28b;VillinCre;Imp1fl/fl mice also display decreased H2AX foci (Zhou et al. 2015) as 
compared to Villin-Lin28b mice, thus indicating less DNA damage at day 4 after radiation 
(Supplementary Figure 3C).  
Evaluating IMP1 separately from its function downstream of LIN28B, we 
observed that VillinCre;Imp1fl/fl mice exhibit less weight loss following irradiation 
compared to control Imp1fl/fl mice (Figure 8E) and that the number of regenerative crypt 
foci is increased in VillinCre;Imp1fl/fl mice (Figure 8F & G). Crypt regeneration in 
VillinCre;Imp1fl/fl mice was evaluated further by plating post-irradiated crypts in 3D 
enteroid culture (Fuller et al. 2012) (Figure 8H). Crypt enteroids from untreated Imp1fl/fl 
and VillinCre;Imp1fl/fl mice establish and grow at similar rates under homeostasis 
(Supplemental Figure 4A); however, post-irradiated crypt from VillinCre;Imp1fl/fl mice 
exhibit a significant increase in enterosphere formation as well as growth into enteroids 4 
days after plating (Figure 8I).  
Our data demonstrating that Imp1 deletion enhances Lin28b-mediated 
tumorigenesis and regeneration in both wild type and Villin-Lin28b mice may counter 
current views of IMP1 function. We therefore generated mice in which Imp1 is 
overexpressed in the intestinal epithelium (VillinCre Imp1OE; Supplemental Figure 4B&C) 
to evaluate mechanistic reversal of phenotypes observed in VillinCre;Imp1fl/fl mice. We 
analyzed aged mice (10-12 months) and found no tumors (Figure 9A) or any significant 
difference in intestinal morphology or Ki67+ proliferating cells between VillinCre Imp1OE 
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and control mice (Figure 9B). We did not observe a significant difference in Paneth, 
goblet or enteroendocrine cell numbers (Supplemental Figure 5). Intriguingly, irradiated 
VillinCre;Imp1OE mice did not exhibit significant differences in weight loss compared to 
control mice at day 4, though there was a trend for increased weight loss in VillinCre 
Imp1OE mice ( Figure 9C). Taken together, these data confirm that IMP1 overexpression 
by itself is insufficient to initiate tumors in the intestine. 
We observed upregulation of Wnt targets in Lin28b;VillinCre;Imp1fl/fl mice. To 
evaluate whether VillinCre; Imp1OE mice exhibit opposing effects, we analyzed gene 
expression in Villin-Lin28b;VillinCre;Imp1OE mice. Analysis of 3-month old mice revealed 
a trend for decreased Wnt target gene expression in Villin-Lin28b;VillinCre;Imp1OE 
compared to Villin-Lin28b mice, supporting the hypothesis that Imp1 may serve as a 
“switch” for canonical Wnt target gene regulation in the context of Lin28b overexpression 
(Figure 9D). Finally, analysis of aged Villin-Lin28b;VillinCre;Imp1OE mice revealed a 
suppression of tumor incidence compared to Villin-Lin28b mice (Figure 9A). In summary, 
the functional effects observed in mice with Imp1 loss or overexpression provide 
evidence that Imp1 acts as a suppressor of the epithelium’s proliferative response under 
non-transformed conditions, due in part via regulation of Wnt signaling. In this regard, 
high IMP1 in CRC patients is likely an “effect” rather than a “cause” of tumor initiation.  
 
IMP1 plays a functional role in reserve intestinal stem cells  
We performed RNA-Seq followed by GSEA on isolated crypts from Imp1fl/fl and 
VillinCre;Imp1fl/fl mice to evaluate baseline changes in gene expression with Imp1 loss. 
Similar to Villin-Lin28b;VillinCre;Imp1fl/fl mice, crypt gene expression analysis in 
VillinCre;Imp1fl/fl mice revealed an increase in intestinal stem cell and Wnt target gene 
expression (Supplemental Figure 6A and Figure 10A). GSEA revealed enrichment of 
gene targets involved in proliferation, regeneration and Wnt signaling in VillinCre;Imp1 fl/fl 
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mice compared to control mice (p-value < 0.001, FDR < 0.001). 
VillinCre;Imp1fl/fl mice lack Imp1 in all intestinal epithelial cells, including stem, 
progenitor, and differentiated cells. Based upon the upregulation of stem cell-related and 
Wnt target genes in VillinCre;Imp1fl/fl mice, we reasoned that Imp1 may exhibit a 
functional role within the intestinal crypt compartment. To confirm Imp1 gene expression 
in small intestine crypt cells, we utilized Sox9-EGFP reporter mice, in which sub-
populations of intestinal epithelial cells are fractionated by their relative EGFP 
expression using fluorescent activated cell sorting (FACS). Sox9-EGFP negative, 
sublow, low, and high segregate into populations of differentiated cells, progenitor/ 
transit-amplifying cells, active crypt base stem cells, and a mixed population of reserve 
stem cells/secretory progenitors/enteroendocrine cells, respectively (Formeister et al. 
2009; Gracz et al. 2010; Van Landeghem et al. 2012; Roche et al. 2015). 
Subpopulations were validated previously with gene expression and functional assays.  
In Sox9-EGFP mice, Imp1 expression is significantly higher Sox9-EGFP low and high 
cells as compared to differentiated lineages (Sox9-EGFP negative cells) (Figure 10B). 
Furthermore, Imp1 expression is upregulated in all cell populations following whole body 
irradiation with a significant increase in Sox9-EGFP high cells relative to other cells 
types (Supplementary Figure 6B).  
 To determine if the protective effect of Imp1 loss persists in a more restricted 
epithelial population, we crossed Imp1fl/fl to mice harboring the HopxCreERT2 knockin 
allele (Wang et al. 2016a), which is expressed specifically in WntNegative quiescent reserve 
stem cells (Li et al. 2014; Yousefi et al. 2016) (Takeda et al. 2011). Similar to 
VillinCre;Imp1fl/fl mice, we found that HopxCreERT2;Imp1fl/fl mice exhibit less weight loss 
following irradiation compared to controls (Figure 10C) and an increase in regenerative 
crypt foci, consistent with enhanced recovery following injury (Figure 10D&E). Taken 
together, these data support a role for IMP1 induction to negatively regulate WNT 
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signaling during homeostasis, putatively in crypt cells with an inactive canonical Wnt 
signaling pathway during homeostasis.  
In total, we propose a model in which LIN28B overexpression promotes 
increased proliferation and tumorigenesis and enhances IMP1 expression, which may 
then feedback and suppress these pathways during homeostasis (Figure 11). This 
mechanism is reinforced by data in Lin28b;VillinCre;Imp1fl/fl mice, where Imp1 loss 
enhances Lin28b-mediated tumorigenesis and upregulates Wnt signaling, and in Villin-




In the current study, we use ribosome profiling to demonstrate that IMP1 acts as 
a pivotal regulator downstream of LIN28B and that IMP1 deletion promotes changes to 
both mRNA levels and translational efficiency. Globally, there is partial overlap in genes 
that are regulated at the mRNA and translation levels, suggesting that IMP1 may 
regulate both homeostatic transcript abundance and translational efficiency for a subset 
of target transcripts. In addition, we found no correlation between the binding efficiencies 
of targets from eCLIP studies (Conway et al. 2016) and the changes in their translation 
efficiencies through ribosome profiling. This notion is supported by recent studies 
comparing eCLIP-identified IMP1-bound targets with gene expression changes in IMP1-
depleted cells, where there was no significant correlation between binding and trends in 
genes expression changes (Conway et al. 2016). Additionally, there are targets that are 
not revealed in the eCLIP studies but are found to be differentially regulated by ribosome 
profiling, highlighting the tissue-specific as well as potentially direct/indirect roles of IMP1 
on gene expression. Our data support the significance of evaluating both the 
transcriptome and translatome simultaneously to understand RBP function and that 
 47 
evaluating translational reinforcement, antagonism, and buffering may uncover 
additional roles for RBPs to refine the functional outcome of a gene or pathway.  
 LIN28B is a critical pluripotency factor and is engaged in diverse cancer types, 
including colorectal cancer(Rahkonen et al. 2016; Zhang et al. 2016; Tsanov et al. 
2017). LIN28B acts to a major extent through the post-transcriptional downregulation of 
the let-7 microRNA (miR) family.  This enables the induction of let-7 mRNA targets, 
which are normally suppressed. In most contexts, this should lead to enhanced 
proliferation, growth and presumably a pathway towards transformation. While the let-7 
mRNA targets are many, e.g. CyclinD1, HMGA2, IMP1, IMP2, it is remains elusive how 
precisely LIN28B exerts its actions through the let-7 mRNA targets. Herein, we find that 
IMP1 regulates the translation efficiency of genes downstream of LIN28B, with one node 
through Wnt signaling pathway components. Pathway analyses highlight several 
pathways involved in cancer (affecting proliferation, migration, differentiation, and 
apoptosis), including WNT signaling, are significantly enriched with Imp1 deletion and 
concurrent Lin28b expression.  These genes are regulated by changes in translational 
efficiencies by differential binding of ribosomes on the transcripts, a finding that expands 
substantially our knowledge about IMP1 and WNT signaling, building upon previous 
studies that β-catenin induces IMP1 transcription and IMP1 stabilizes β-catenin 
mRNA(Gu et al. 2008).  
We demonstrate that Imp1 loss in Lin28b transgenic mice promotes a robust 
increase in high-grade tumors exhibiting phenotypically less differentiation and a more 
invasive phenotype, upregulation of stem/progenitor cell genes, and enhanced nuclear 
β-catenin, suggesting Imp1 loss may promote expansion of the intestinal stem cell 
compartment. This is in contrast to data in neural stem cells, where Imp1 deletion 
promoted differentiation(Nishino et al. 2013). Similarly, the finding that Imp1 loss 
promotes tumorigenesis in the intestinal epithelium is in contrast to prior studies 
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suggesting IMP1 may act as an oncogene in different tissues (Tessier et al. 2004; Kobel 
et al. 2007; Mayr and Bartel 2009; Hamilton et al. 2013; Gutschner et al. 2014). 
However, more recent studies have identified tumor-suppressive roles of IMP1 as well 
(Hamilton et al. 2015; Wang et al. 2016a).  These divergences likely depend upon 
numerous factors, including age, the compartment in which Imp1 is expressed (for 
example epithelial versus mesenchymal), the specific tissue type (intestinal, breast, 
brain, etc.) and whether Imp1 loss is acting alone or in concert with known oncogenes. 
IMP1 stabilizes β-catenin mRNA in breast cancer cells (Gu et al. 2008) and is in turn 
activated by it in a feedback mechanism(Gu et al. 2009). In other studies, IMP1 was 
shown to bind and stabilize beta-TRCP1, a β-catenin antagonist (Elcheva et al. 2009) . 
Hence, we used unbiased approaches (RNA sequencing and ribosome 
profiling/sequencing) to evaluate global changes in pathways with IMP1 loss and then 
used in vivo mouse models to understand the net effects upon WNT pathway signaling. 
However, our data do not necessarily exclude a role for IMP1 in tumor progression, 
where it may exhibit different roles based upon target transcript abundance. 
  Although LIN28B has been reported to range from 30-75% of colorectal cancer 
tumors (Piskounova et al. 2011) (Tu et al. 2015), IMP1 is overexpressed in up to 80% 
(King et al. 2011a) (Mongroo et al. 2011).  This suggests that the LIN28B-Let7-IMP1 axis 
may function under certain scenarios, but other LIN28B-independent factors, yet to be 
identified in colorectal cancer, may still regulate IMP1 expression. This is supported by 
our TCGA analysis where LIN28B and IMP1 expression do not positively correlate at all 
stages of colon cancer. Importantly, our finding that VillinCre;Imp1OE mice do not exhibit 
spontaneous tumor initiation suggest that IMP1 overexpression is itself insufficient to 
drive tumor initiation.  To that end, it is possible that IMP1 overexpression may serve as 
a “brake” or “checkpoint” to the oncogenic effects of LIN28B. The “checkpoint” regulation 
may be achieved through a variety of mechanisms ascribed to IMP1, such as 
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sequestration of transcripts in IMP1 containing RNP granules (Weidensdorfer et al. 
2009) (Jonson et al. 2007 ) (to avoid mRNA degradation and/or release the transcripts 
for translation at critical time points), reduction of miRNA mediated silencing of mRNA 
transcripts (Elcheva et al. 2009; Nishino et al. 2013; Busch et al. 2016; Degrauwe et al. 
2016a) (for review see (van Kouwenhove et al. 2011)), or displacing miRNA containing 
RISCs (Elcheva et al. 2009). IMP1 may also enhance the expression of LIN28B by 
shielding LIN28B mRNA from regulation by let-7 in vitro (Busch et al. 2016). Additionally, 
Lin28b and drosophila Imp1 (dImp1) cooperate for mitotic activity and oncogenesis 
(Narbonne-Reveau et al. 2016).  Furthermore, LIN28B and IMP1 may cooperate to 
augment cellular bioenergetics, and in the case of LIN28B, cell metabolism (Tu et al. 
2015).   
Targeting key pathways in colorectal cancer remains challenging as so many of 
these pathways are important for normal epithelial homeostasis. The targeting of RBPs 
can be refined to interrupt specific RBP:RNA transcript interactions. LIN28B and IMP1 
exhibit low expression in most adult tissues, suggesting that targeting them may have 
few deleterious effects. Inhibitors for LIN28B would prevent aberrant blockade of tumor 
suppressor let-7, whereas a specific IMP1 inhibitor would require targeting of tumor-
promoting interactions while sparing tumor suppressor functions. For example, a novel 
IMP1 inhibitor that targets c-Myc specifically has demonstrable effects on melanoma and 
ovarian cell proliferation; however, studies have been limited to in vitro assays thus far 
(Mahapatra et al. 2014; Mahapatra et al. 2017). In summary, our findings highlight the 
LIN28B/IMP1 signaling axis as a key regulon for normal homeostasis and tumorigenesis 
in the intestinal epithelium, providing mechanistic insight into the basic biology of RBPs 
as well as underscoring the importance of understanding post-transcriptional regulation 
of principle oncogenic pathways in vivo.  
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Figures and figure legends 
 
Figure 6: IMP1 is a significant translational regulator downstream of LIN28B 
 
A. Radar map demonstrating top post-transcriptional regulators of differentially 
expressed genes with LIN28B overexpression in SW480 cells as compared to control 
cells. A single point on the radar map indicates -10 log p-value of enrichment of any 
post-transcriptional regulator. Differentially expressed genes at each level were identified 
using the DEGseq and the list of post-transcriptional regulators was obtained from the 
AURA database (see methods).  
B. Scatterplot of differential expression between LIN28B overexpressing lines with and 
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The log2 fold changes between ribosome-bound RNAs (ribosome protected fragments, 
or RPF) and total mRNA are plotted. The plot indicates that IMP1 regulates both mRNA 
abundance and translation.  C. Scatterplot of genes with significant (in blue) differential 
translational efficiencies between LIN28B overexpressing cells with and without IMP1 
deletion. Translation efficiencies (TE) of the transcripts are calculated as the ratio of 
reads of ribosome-protected fragments to the reads in total mRNA abundance. D. 
Pathway analysis using DAVID software of the differentially expressed genes from C to 





Figure 7: IMP1 loss enhances LIN28B-mediated tumorigenesis in vivo.  
 
Imp1fl/fl (Wild Type), Villin-Cre;Imp1fl/fl , Villin-Lin28b , Villin-Cre;Villin-Lin28b;Imp1fl/fl were 
aged up to one year and then sacrificed to evaluate tumor growth. A. Igf2bp1/Imp1 
expression in the epithelium isolated from jejunum of 12-month-old mice (n>4 mice per 
genotype). B. Representative immunofluorescence staining for EdU incorporation in 
mouse intestinal epithelium. (Scale bars = 500m) C. Quantification of EdU+ve cells 
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using flow cytometry (n=3 mice per genotype) D. Number of intestinal tumors in mice 
with or without Imp1 in the context of Lin28b overexpression (n> 9 mice per genotype). 
E. Percentage of tumors classified as adenocarcinomas by histological scoring. F. 
Representative H&E staining of intestinal epithelium in aged mice. Mice lacking Lin28b 
overexpression exhibited normal intestinal morphology at 12 months of age. Mice with 
Lin28b overexpression exhibited tumor development that worsened with Imp1 loss. 
(Scale bars = 500m) G. Relative expression of different let-7 targets in the intestinal 
epithelium via qPCR (n> 5 mice per genotype). H. Relative expression of stem cell 
markers in the intestinal epithelium via qPCR expressed as fold change with respect to 
Imp1fl/fl mice (n> 5 mice per genotype). I. Relative expression of Wnt target genes in 
intestinal epithelium via qPCR expressed as fold change with respect to Imp1fl/fl mice (n> 
5 mice per genotype). J. Representative immunohistochemical staining for β-catenin in 
mouse intestinal epithelium (magnified in inset). K. Representative β-catenin protein 
levels in mouse intestinal crypts from the four genotypes.  
(All data are expressed as mean ± SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****,  < 
0.0001 by ordinary one-way ANOVA test followed by Tukey’s multiple comparison test. 





Figure 8: IMP1 regulates intestinal epithelial regeneration following irradiation.   
 
Mice were evaluated for Imp1 expression in non-irradiated (non-IR) and 4-days post 12 
Gy whole body IR. A. qRT-PCR and representative western blot for Imp1 in isolated 
crypts from these mice. *P<0.05 vs. non-IR, N=3-4 mice per genotype. B. 
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Representative immunohistochemical staining showing Imp1 increase in wildtype 
(Imp1fl/fl) mice following radiation. VillinCre;Imp1 fl/fl mice are used as controls (Scale bars 
= 500m). C. Villin-Lin28b; Villin-Cre;Imp1fl/fl mice lost significantly less weight at 
sacrifice following irradiation than Villin-Lin28b mice (22.23 ± 0.9905% mean weight loss 
in Villin-Cre;Villin-Lin28b;Imp1fl/fl mice (n=3) versus 26.68 ± 0.4076% in Villin-Lin28b 
(n=5)) The weight loss in Villin-Lin28b mice was significantly higher than in controls 
(22.24 ± 0.2556% mean weight loss). D. Analysis of Ki67+ cells revealed a significant 
increase in Ki67+ regenerative crypt foci in VillinCre Villin-Lin28b;Imp1 fl/fl mice at 4 days 
following irradiation(n=3-4 mice per genotype, 20-30 HPF per mouse). Representative 
immunohistochemical staining for Ki67+ foci in the mouse intestinal epithelium is shown. 
(Scale bars = 500m).  E. VillinCre;Imp1 fl/fl mice lost significantly less weight at sacrifice 
following irradiation than controls (18.83 ±0.98% in VillinCre;Imp1 fl/fl mice versus 23.34 
±0.56% mean weight loss in controls). (n =14 Imp1fl/fl and 12 VillinCre;Imp1 fl/fl mice). F. 
Analysis of Ki67+ cells revealed a robust increase in Ki67+ regenerative crypt foci in 
VillinCre;Imp1 fl/fl mice at 4 days following irradiation (n=4 mice per genotype, 20-30 HPF 
per mouse). G. Representative immunohistochemical staining for Ki67+ foci in mouse 
intestinal epithelium. (Scale bars = 500m) H. Representative pictures of enterosphere 
and enteroid with buds. Enhanced growth of post-irradiation enteroids from 
VillinCre;Imp1 fl/fl mice. Regenerative crypt units were plated in enteroid culture on the 
day of sacrifice to evaluate ex vivo survival and growth. I. Evaluation of enterosphere 
growth 1 day following plating and enteroid growth 4 days after plating (revealed a 
significant increase in VillinCre;Imp1 fl/fl compared to Imp1fl/fl. (All data are expressed as 
mean ± SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****,  < 0.0001 by ordinary one-way 
ANOVA test followed by Tukey’s multiple comparison test. The significance is shown 
compared to control/wildtype samples unless indicated otherwise)  
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Figure 9: IMP1 overexpression does not initiate tumors in vivo. 
 
A. The VillinCre;Imp1OE mice did not exhibit tumor formation between 10-12 months of 
age. B. Representative H&E and Ki67 staining of intestinal epithelium in aged (10-12 
months) mice. Mice overexpressing IMP1 exhibited normal intestinal morphology and did 
not show a tumor phenotype (Scale bars = 500µm). C. Relative expression of Wnt target 
genes in the intestinal epithelium via qPCR expressed as fold change with respect to 
wildtype control mice at 10-12 months of age (n= >4 mice per genotype). (All data are 
expressed as mean ± SEM. *, p < 0.05;  
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**, p < 0.01; ***, p < 0.001; ****,  < 0.0001 by ordinary one-way ANOVA test followed by 
Tukey’s multiple comparison test).  
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Figure 10: IMP1 plays a functional role in reserve intestinal stem cells.  
 
A. qRT-PCR for stem cell markers and Wnt target genes in isolated crypts from 
VillinCre;Imp1fl/fl mice compared to Impfl/fl mice. (n=3-4 mice per genotype). B. qPCR in 
Sox9-EGFP reporter mice, where epithelial cell populations are  
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sub-classified via FACS into Sox9-EGFP negative, sublow, low and high cells. Imp1 is 
expressed at low levels in all represented cell types except Sox9-EGFP negative cells 
(white bars). Imp1 expression is significantly higher in  
Sox9-EGFP low and high cells, which encompass intestinal stem cells (n=5 animals per 
group). C. HopxCreERT2;Imp1fl/fl mice lost significantly less weight at sacrifice following 
irradiation than controls (18.8 ± 1.951% mean weight loss in HopxCreERT2;Imp1fl/fl 
mice versus 23.92 ± 1.015% in controls). (n =8 HopxCreERT2;Imp1fl/fl and n=12 control 
mice). D. Analysis of Ki67+ cells revealed there was a robust increase in Ki67+ 
regenerative crypt foci at 4 days following irradiation in HopxCreERT2;Imp1fl/fl mice 
compared to control mice, (n=4 mice per genotype, 20-30 HPF per animal) (Scale bars = 
500μm). E. Representative immunohistochemical staining for Ki67+ foci in mouse 
intestinal epithelium quantified in D. F. qPCR for Imp1 expression in Lgr5+ and Paneth 
(CD24/cKit/SSC high) cells sorted from Lgr5-eGFP-IRES-CreERT2 mouse crypts. All 
data are expressed as mean ± SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 




Figure 11: IMP1 is the principal node for post-transcriptional regulation 
downstream of LIN28B.  
 
We propose a model in which IMP1 plays an important regulatory role downstream of  
LIN28B. Both LIN28B overexpression and whole-body irradiation enhance IMP1 
expression in the intestinal epithelium. Deletion of IMP1 causes a significant increase in 
LIN28B-mediated tumorigenesis, likely due in part to observed increases in Wnt 
signaling and potentially stem cell signature. Furthermore, IMP1 loss (specifically in 
Hopx+ stem cells) causes increased regeneration following radiation injury. Taken 
together, these data suggest IMP1 as a regulator of intestinal epithelial  




Supplementary Figure 1  
 
A. Representative western blot demonstrating LIN28B and IMP1 expression in SW480 
cells. Wild type SW480 cells express endogenous IMP1 that increases with LIN28B 
overexpression (OE). CRISPR-cas9-mediated deletion of IGF2BP1 (IMP1) in SW480 
cells (WT and LIN28B OE). SW480 cells do not express LIN28B endogenously. B. 
Scatterplot of binding efficiencies of RNA targets of IMP1 identified by enhanced UV 
crosslinking and immunoprecipitation (eCLIP) (Conway et al. 2016) with differential 
translational efficiency of the targets identified in 1C. We find no significant correlation 
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between the two (R2=0.0024). C. qRT-PCR for Wnt target genes in SW480 cells 
overexpressing LIN28B with and without IMP1 deletion. (n=3 passages). Several Wnt 
targets are significantly upregulated with IMP1 deletion. D. Western blot showing ß-
CATENIN increase with IMP1 deletion in SW480 cells with LIN28B overexpression. (* 




Supplementary Figure 2 
 
A. Representative western blots demonstrating LIN28B and IMP1 expression in LoVo 
cells. Wild type (WT) LoVo cells show undetectable IMP1 expression that was increased 
with LIN28B OE. CRISPR-cas9-mediated deletion of IGF2BP1 (IMP1) in LoVo cells (WT 
and LIN28B OE). B. Xenograft (subcutaneous) experiments with LoVo cells (n=10 per 
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cell type) show a significant decrease in tumor size with LIN28B overexpression (169.9 ± 
31.12 mm3 at sacrifice) as compared to WT cells (1145 ± 120.3 mm3 at sacrifice). This 
effect is partially rescued with IMP1 knockout (417.6 ± 107.7 mm3 at sacrifice). C. 
Representative histological sections of the xenografts from B show highly differentiated 
tumors in LoVo cells with LIN28B overexpression. This is not observed in tumors from 
WT LoVo cells or LIN28B overexpressing LoVo cells with IMP1 deletion where the 
tumors are poorly differentiated and express more ß-catenin staining (Scale bars = 
500m). D. Relative expression of Wnt target genes in xenograft tumors from B (n> 4 
tumors per genotype).  E. Table showing differentiation status of LIN28B overexpressing 
human colorectal tumors from tumor tissue microarray (matched normal and tumor 
samples n=37). A majority of the tumors show increased differentiation. F. 
Representative western blot showing LIN28B expression in the intestinal epithelium of 
the 4 genotypes. G. Representative western blot showing increased AXIN2 expression 








A. Correlation graph between normalized mRNA expression intensities of LIN28B and 
IMP1 in the colon adenocarcinoma and rectal adenocarcinoma (COADREAD) datasets 
in the Cancer Genome Atlas (Cline et al. 2013) (n=300 patients). LIN28B expression 
significantly correlates positively with IMP1 expression. B. TCGA analysis showing 
LIN28B and IMP1 expressions in different stages of colorectal cancer. IMP1 is 
expressed highly in all four stages irrespective of LIN28B expression levels showing that 
IMP1 expression is potentially regulated by factors in a LIN28 dependent and 
independent fashion. C. Representative H2AX staining in Villin-Lin28b and Villin-
Cre;Villin-Lin28b;Imp1fl/fl mice 4 days after 12Gywhole body radiation. Arrows indicate 
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H2AX foci. (Scale bars = 500μm) D. Quantification of  ß-CATENIN protein via western 
blots of the crypts cells of the mice of the 4 genotypes (n=3 per genotype) 
 
Supplementary Figure 4 
 
A. qRT-PCR for Wnt target genes in CaCo2 cells with IMP1 knockdown as compared to 
controls. (n=3 independent experiments). Several Wnt targets are significantly 
upregulated with IMP1 knockdown. B. Western blot showing IMP1 knockdown using 
siIMP1 in CaCo2 cells. C. Enteroid plating efficiency from Imp1 fl/fl and VillinCre;Imp1fl/fl 
mice at homeostasis revealed no significant difference between genotypes. N=3-7 mice 
per genotype with 4-5 wells per mouse analyzed. D. Construct for Imp1OE mice, which 
were then crossed with VillinCre mice. E. The VillinCre;Imp1OE mice were verified for 
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intestinal IMP1 expression by qRT-PCR in isolated epithelia from these mice. *P<0.05, 









Supplementary Figure 5 
 
A. Representative staining for Ki67 (proliferation), Lysozyme (Paneth cells), Alcian blue 
(goblet cells) and chromogranin A (enteroendocrine cells) in VillinCre;Imp1OE mice as 
compared to controls. (Scale bars = 500μm). B. Villin-Cre;Imp1OE mice lost similar 
weight at sacrifice following irradiation compared to Imp1OE controls. (23.46 ± 0.7485% 
mean weight loss in Villin-Cre;Imp1OE mice (n=9) versus 22.24 ± 0.2556% in Imp1OE 




Supplementary Figure 6 
 
A. Crypts cells from Imp1fl/fl and VillinCre;Imp1fl/fl mice were isolated and RNA-Seq 
performed N=3 mice per group. Gene set enrichment analysis (GSEA) revealed 
enrichment of gene targets involved in proliferation, regeneration and Wnt signaling in 
VillinCre;Imp1fl/fl mice as compared to control mice (p-value < 0.001, FDR < 0.001) 
 70 
(NES = Normalized Enrichment Score; It reflects the degree to which a gene set is 
overrepresented at the top or bottom of a ranked list of genes). B. Imp1 expression is 
upregulated in all the different Sox9-EGFP cell fractions five days following 14Gy 
irradiation and significantly upregulated in the Sublow and High populations (n=5 




Supplemental Tables  
 
Supplemental Table 1: Pathways enriched in SW480 cells with LIN28B 
overexpression and IMP1 deletion  
 
Name NOM p-value FDR  q-value 
Hallmark_E2F_Targets 0 0 
Hallmark_G2M_Checkpoint 0 0 















Hallmark_MYC_Targets_V2 0.015625 0.0267 
Hallmark_UV_Response_Up 0 0.0386 
Hallmark_DNA_Repair 0.012987013 0.0443 
Hallmark_Spermatogenesis 0.006593407 0.0405 
Hallmark_Peroxisome 0.027253669 0.061803464 
Hallmark_MTORC1_Signaling 0.013888889 0.06772548 














Hallmark_Glycolysis 0.08 0.19207256 




























Hallmark_IL2_STAT5_Signaling 0.8098434 0.75037533 
 
 
Supplemental Table 2: Comparison of fold change of transcripts between the 





< 2 fold change > 2 fold increase 
> 2 fold 
decrease 
< 2 fold change 2492 4019 111 
> 2 fold increase 90 235 5 
> 2 fold decrease 153 428 12 
 
 
Supplemental Table 3: List of Wnt signaling pathway genes differentially regulated 
by IMP1 loss with LIN28B overexpression in SW480 cells 
 




Corepressor targeting diverse transcription 
regulators. Acts as a scaffold for 
specialized synapses. Phosphorylated upon 
DNA damage. Phosphorylation by HIPK2 
on Ser-428 induces proteasomal 
degradation. Ubiquitous expression. 
Highest levels in heart, skeletal muscle, and 
pancreas. 
FBXW11 




Substrate recognition component of a SCF 
(SKP1-CUL1-F-box protein) E3 ubiquitin-
protein ligase complex which mediates the 
ubiquitination and subsequent proteasomal 
degradation of target proteins. Probably 
recognizes and binds to phosphorylated 
target proteins. SCF(FBXW11) mediates 
the ubiquitination of CTNNB1 and 
participates in Wnt signaling. 
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WNT10A 
Wnt family member 
10A(WNT10A) 
Ligand for members of the frizzled family of 
seven transmembrane receptors. Probable 
developmental protein. May be a signaling 





Prevents the interaction between CTNNB1 
and TCF family members and acts as 











May play a role in the signal transduction 





May play a role in the signal transduction 




Receptor for Wnt proteins. Lys-Thr-X-X-X-
Trp motif is involved in the activation of the 
Wnt/beta-catenin signaling pathway. The 





Cell autonomous antagonist of the 
canonical Wnt signaling pathway. May 
activate a second Wnt signaling pathway 
that controls planar cell polarity (By 
similarity). Required for processing of TGFA 
and for targeting of TGFA to the basolateral 




Acts downstream of MAP3K7 and HIPK2 to 
negatively regulate the canonical Wnt/beta-
catenin signaling pathway and the 
phosphorylation and destruction of the MYB 
transcription factor. Involved in TGFbeta-
mediated mesoderm induction, acting 
downstream of MAP3K7/TAK1 to 
phosphorylate STAT3. 
PRKCA 




protein kinase C 
gamma(PRKCG) 
This is a calcium-activated, phospholipid-







Phosphorylates a large number of 




3 catalytic subunit 
gamma(PPP3CC) 
Calcium-dependent, calmodulin-stimulated 
protein phosphatase. This subunit may 










substrate 1 (rho 










Materials and Methods 
Cell Lines and Cell Culture 
Colorectal cancer cell lines were obtained from ATCC that STR authenticates them. 
Stable LIN28B expression in SW480 and LoVo cells was achieved using MSCV-PIG-
LIN28B and empty vector control plasmids (gifts from Dr. Joshua Mendell) using the 
protocol described previously (King et al. 2011b). IMP1 was knocked out by co-
transfecting cells with IMP-1 CRISPR/Cas9 KO Plasmid (h) (Santa Cruz; sc-401703) 
and IMP-1 HDR Plasmid (h) (Santa Cruz ; sc-401703 HDR) followed by sorting and 
clonal expansion of RFP+ve cells. The knockout was verified by western blotting for 
IMP1. IMP1 was knocked down in CaCo2 cells by siRNA transfection using 
Lipofectamine RNAiMax as per the manufacturer’s guidelines. Silencer select negative 
control #1 siRNA from ThermoFisher was used as a negative control. qRTPCR was 
used to validate knockdown. Cell lines were cultured in DMEM (Thermo Fisher 
Scientific) supplemented with 10% FBS (GE Healthcare Life Sciences) and 1% 
Penicillin-Streptomycin (P/S; Thermo Fisher Scientific) in a 37 °C incubator with 5% CO2 




VillinCre;Vil-Lin28b;Imp1fl/fl were obtained by mating Vil-Lin28bMed and VillinCre;Imp1fl/fl 
mice that have been described previously (Hamilton et al. 2013; Madison et al. 2013b), 
and were maintained via backcrosses to C57BL/6J. Imp1fl/fl mice were considered wild 
type and express LIN28B and IMP1 insignificantly different from wild type mice. Lgr5-
EGFP-IRES-creERT2 mice were purchased from Jackson Laboratories. The 
HopxCreERT2;Imp1fl/fl mice were generated by crossing Imp1fl/fl mice with tamoxifen 
inducible Hopx-CreERT2 (JAX strain 017606) mice that were generated at the University 
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of Pennsylvania in the laboratory of J. Epstein (Philadelphia, PA) and have been 
characterized previously (Yousefi et al. 2016). Sox9-EGFP mice were maintained as 
previously described (Van Landeghem et al. 2012). We utilized Cyagen (Santa Clara, 
CA) to generate Imp1 overexpressing (Imp1OE) mice. Briefly, the knockin construct was 
generated by amplification of mouse genomic fragments from a BAC clone using high-
fidelity DNA polymerase. The targeting vector was assembled to include Flag-tagged 
Imp1 (Igf2bp1) cDNA targeted to the Rosa locus downstream of the EF1α promoter and 
PolyA sequence flanked by loxP sites (Supplemental Figure 4B). In addition, we 
included an IRES;tdTomato;SV40EpolyA following the Imp1 cDNA. We crossed these 
mice with Villin-Cre mice in order to specifically overexpress Imp1 in intestinal epithelial 
cells. All experimental analyses were performed on three or more individual mice (male 
or female mice at 12 months of age for tumor studies and 8-12-week-old mice for 
irradiation studies). Controls and experimental groups were either sex-matched 
littermates or age-matched, sex-matched non-littermates. To ablate Imp1 in 
HopxCreERT2;Imp1fl/fl mice, tamoxifen (Sigma-Aldrich) was dissolved in peanut oil at 10 
mg/ml, and 200g/g of body weight tamoxifen was injected intraperitoneally for each 
dose. A total of 2 doses were administered 24 hours apart before the irradiation 
experiments.  12 Gy whole-body γ-IR was administered to at least three mice in each 
group. For irradiation experiments utilizing VillinCre;Impfl/fl mice, animals were given a 
whole body, single dose of 12Gy using the Gammacell 40 Cesium 137 Irradiation Unit. 
Irradiation of Sox9-EGFP mice was performed as described previously (Van Landeghem 
et al. 2012). Body weights were recorded daily, and mice were euthanized before losing 
a maximum of 25% total body weight at day 4 post-irradiation. All mouse protocols were 
approved by the Institutional Animal Care and Use Committee at the University of 




Ribosome profiling libraries from 3 pooled cell culture plates were prepared using a 
standard protocol (McGlincy and Ingolia 2017), with minor modifications. Separate 5’ 
and 3’ linkers were ligated to the RNA-fragment instead of 3’ linker followed by 
circularization (Subtelny et al. 2014). 5’ linkers contained 4 random nt unique molecular 
identifier (UMI) similar to a 5 nt UMI in 3’ linkers. During size-selection, we restricted the 
footprint lengths to 18-34 nts. Matched RNA-seq libraries were prepared using RNA that 
was randomly fragmentation by incubating for 15 min at 95C with in 1 mM EDTA, 6 mM 
Na2CO3, 44 mM NaHCO3, pH 9.3. RNA-seq fragments were restricted to 18-50 nts. 
Ribosomal rRNA were removed from pooled RNA-seq and footprinting samples using 
RiboZero (Epicenter MRZH116). cDNA for the pooled library were PCR amplified for 15 
cycles.  
 
Ribosome profiling data processing and analysis 
RNA-seq and footprinting reads were mapped to the human transcriptome using the 
riboviz pipeline(Oana Carja 2017b). Sequencing adapters were trimmed from reads 
using Cutadapt 1.10 (Martin 2011) (--trim-n -O 1 –minimum-length 5). The reads from 
different samples were separated based on the barcodes in their 3’ linkers using 
fastx_barcode_splitter (FASTX toolkit, Hannon lab) with utmost one mismatch allowed. 
UMI and barcodes were removed from reads in each sample using Cutadapt (--trim-n -m 
10 -u 4 -u -10). Trimmed reads that aligned to human/mouse rRNA were removed using 
Bowtie v1.1.2 (Langmead et al. 2009). Remaining reads were mapped to a set of 19,192 
principal transcripts for each gene in the APPRIS database (Rodriguez et al. 2013) 
(using HISAT2 v2.1.0 (Kim et al. 2015)). Only reads that mapped uniquely were used for 
all downstream analyses. For genes with multiple principal transcripts, the first one in the 
list was chosen. Codes for selecting these transcripts were obtained from riboviz 
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package (https://github.com/shahpr/RiboViz, (Oana Carja 2017a)). Radar map: The list 
of post-transcriptional regulators was obtained from the AURA database (Dassi et al. 
2014) and the plot was generated using modified functions of tRanslatome (Tebaldi et al. 
2014) package in R. The tRanslatome package was modified to restrict the list of post-
transcriptional regulators to regulators of 19,192 genes used for mapping reads. All 
analyses of ribosome profiling datasets were performed in R. We restricted analyses to 
genes with at least one dataset (RNA-seq or footprinting across conditions) with 64 
mapped reads and genes with 0 read counts in any dataset were ignored unless the 
mean read counts across all 8 datasets was above 64. Differentially expressed genes 
were identified using DEGseq package (Wang et al. 2010) using an FDR cutoff of 0.001. 
GO enrichment analyses and identification of post-transcriptional regulators of 
differentially expressed genes at the transcriptome and translatome levels was 
performed using tRanslatome package. 
 
RNA Sequencing 
RNA was isolated from freshly isolated mouse intestine crypts and cell lines using the 
GeneJET RNA Purification Kit  according to the manufacturer’s instructions, with DNase 
treatment. The cDNA libraries were then generated using Illumina TruSeq Stranded 
mRNA Library Preparation Kit with Ribo Zero treatment (RS-122-2201). The cDNA was 
sequenced using HiSeq 50 Cycle Single-Read Sequencing version 4 by the High 
Throughput Genomics core at the Huntsman Cancer Institute, University of Utah for a 
fee. All sequencing reads were first trimmed to remove 3’ sequencing adapters, and 
aligned to the hg19 human genome with STAR using the default parameters(Dobin et al. 
2013). Read counts for each gene were measured using HTSeq run in “intersection-
strict” mode(Anders et al. 2015), and differential expression analysis was performed 
using DESeq2(Love et al. 2014). Taking all differentially expressed genes with a false 
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discovery rate (FDR) < 0.05, GO analysis was performed using DAVID(Huang da et al. 
2009b; Huang da et al. 2009a). Genotypes were run in triplicates and DESeq2 analysis 
was performed on them. GO Analysis was performed on the differentially expressed 
genes. GSEA was performed according to previously established guidelines 
(Subramanian et al. 2005).   
 
TCGA Analyses 
Publicly available gene expression data from The Cancer Genome Atlas (TCGA) were 
downloaded from the Genomic Data Commons (GDC) Data Portal and graphs 
generated using GraphPad Prism. Tumor type and stage data were acquired from the 
University of California Santa Cruz (UCSC) Xena at http://xena.ucsc.edu. Pooled Colon 
and rectal adenocarcinoma (COADREAD) data contained 433 samples in different tumor 
stages. For staging, high expression and low expression groups were determined by 
cutoff at the 75th percentile.  
Correlation of expression was determined via Chi-square analysis; 95% confidence 
interval calculated for confirmation of statistical significance in GraphPad Prism. 
 
Tumor Tissue Microarray Analysis 
A tumor tissue microarray comprised of a uniform cohort of 228 (133 males and 95 
females) patients with colon carcinoma (88 in stage 2, and 140 in stage 3) diagnosed 
between November 1993 and October 2006 was used. Rectal tumors were 
excluded(King et al. 2011a). LIN28B staining intensity was scored by a pathologist 
(A.J.K.S.) - 1 was used to signify low Lin28b intensity, 2 for intermediate intensity, and 3 
for high. We used the high expressing samples and analyzed the differentiation status by 
the three-tier tumor grading system recommended by the American Joint Commission 
(Edge and Compton 2010). 
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Enteroid Culture and Analyses 
The proximal jejunum (6cm) was flushed with cold PBS and cut lengthwise to expose the 
luminal surface.  Tissue was placed in calcium-magnesium-free HBSS (CMF-HBSS) 
with 1 mM N-acetyl cysteine, vortexed briefly, and placed on ice. The tissue was then 
transferred to CMF-HBSS containing 10 mM EDTA and 1 mM NAC and incubated for 45 
minutes at 4°C with end-to-end rotation. Epithelial cells were then mechanically 
dissociated by vortexing for 30 seconds, following a rest on ice for 30 seconds, repeated 
for a total of 4 times.  The villi were removed by filtering over a 70µm filter. Crypts were 
pelleted at 100 x g for 4 minutes and resuspended in Basal+ Media (Advanced 
DMEM/F12 containing: 2mM, 10mM HEPES, 1X Penicillin/Streptomycin, 5µM 
CHIR99021, 1mM NAC, 1X N2 supplement, and 1X B27 supplement for quantification. 
Crypts were defined as small, U-shaped structures (or partial U-shaped structures for 
irradiated mice).  Crypts were plated in 4 wells of a 48-well plate per mouse at a density 
of 150 crypts per well in an 80/20 mixture of Matrigel Matrix and Basal+ Media also 
containing 50ng/mL mouse epidermal growth factor and 2.5% Noggin/R-spondin 
conditioned media (Sato et al. 2009). After Matrigel solidified, crypt-containing patties 
were overlaid with ENR media.  The number of surviving crypt spheres (enteroids) were 
counted on day 1-4 following plating to determine enteroid plating efficiency.  On day 4 
after plating the number of surviving enteroids was scored.  All counting was performed 
at 10X magnification using the Olympus IX81 inverted microscope.  A crypt sphere was 
defined as a 3-D sphere or oval shape surrounding a lumen (ie enterosphere).  A 
“budded” enteroid was defined as a 3-D structure with one or more de novo projections 




Small intestine crypt RNA was isolated using the GeneJet RNA purification kit. Equal 
amounts of total RNA were reverse-transcribed using the Taqman RT Reagents kit and 
resulting cDNA used with Power SYBR Green PCR Master Mix and validated primer 
sets listed in the table below. Non-reverse transcribed samples were used as negative 
controls, and gene expression was calculated using the R = 2(−ΔΔCt) method, where 
changes in Ct values for the genes of interest were normalized to housekeeping genes 
Tbp, Rsp6 or Gapdh. Gene expression data are expressed as fold-change versus mean 
values for wild type or no treatment controls. All experiments were replicated in at least 3 
independent experiments with technical replicates (duplicates) in each experiment. For 
analyses of Sox9-EGFP mice, FACS-isolation of Sox9-EGFP cell populations was 
performed as described previously (Van Landeghem et al. 2012). Total RNA from all 
Sox9-EGFP populations and non-sorted epithelial cells were extracted and reverse 
transcribed. qRT-PCR was performed using Platinum Quantitative PCR SuperMix-UDG 
and the following TaqMan probes: Mm00501602_m1 (Igf2bp1) and Mm02342456_g1 
(Rsp6). Samples were run in duplicate and expression was determined by a standard 
curve of pooled non-sorted intestinal epithelial cells and normalized to the invariant 
control gene Rps6. 
 
Histology, Immunohistochemistry and Tissue Analyses 
Tissues were fixed in zinc formalin fixative overnight at 4°C, washed in PBS, and moved 
to 70% ethanol before paraffin embedding and sectioning. Hematoxylin and eosin (H&E) 
staining was performed according to standard procedures in the Molecular pathology 
and imaging core of the Penn Center for Molecular Studies in Digestive and Liver 
Diseases. For immunostaining, antigen retrieval was performed by heating slides in 
10mM citric acid buffer (2.1g Citric Acid Monohydrate in 1L di H2O, pH 6.0) in a pressure 
cooker. The images were taken using Nikon Eclipse E600 Microscope and analyzed with 
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the NIS-Elements Basic Research software version 4.51. Imaging was performed at RT. 
The following primary antibodies were used for immunostaining: anti-Ki67 antibody 
(1:200), anti-LYSOZYME (1:1000), anti-CHROMAGRANIN A (1:1000), anti-H2AX 
(1:1000), anti-IMP1 antibody (1:1000), anti-AXIN2 (1:4000), anti–β-CATENIN antibody 
(1:1000). Cy2- or Cy3-, conjugated secondary antibodies were obtained from Jackson 
ImmunoResearch Laboratories, Inc. Biotinylated secondary antibodies and DAB 
substrate kit for immunohistochemistry were purchased from Vector Laboratories. All 
quantifications were done across at least 30 high-powered fields per animal that were 
randomly selected areas throughout the small intestine of at least four mice in each 
genotype. For quantifying regeneration after irradiation, regenerative microcolonies/foci 
were defined as a cluster of ≥5 Ki67-positive cells from a single clone (colony or 
hyperproliferative crypt).  
 
Flow cytometry and sorting 
For analysis of EdU positive cells, the mice were injected with 20mg/kg of EdU 
intraperotoneally. The mice were sacrificed 2 hours after the injection. The single cell 
suspensions of crypt-enriched intestinal epithelium from the small intestine (jejunum) of 
the mice were then stained for EdU following the manufactures instructions. For sorting, 
mouse intestinal epithelial cells were isolated into single cells. CD24-PE (Biolegend) and 
cKit PE-Cy7 (eBioscience) staining was done for sorting as per manufacturer’s 
instructions.Flow cytometry was performed using a FACS LSR (BD Biosciences) with a 
100μm nozzle. Sorting was done using FACS Aria (BD Biosciences) sorter. Gating and 
compensation were performed using a negative and single-color controls. Three 
biological replicates (and three technical replicates) for each genotype were used.  
 
Quantification and Statistical Analysis 
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Statistical analysis was performed using GraphPad Prism software version 7.0. One-way 
ANOVA with Tukey’s post-hoc test was performed to compare the differences among 
groups in all studies. Unpaired t-test (two-tailed) was used when two groups were 
compared. For all experiments with error bars, the standard error of the mean was 
calculated, and the data are presented as mean ± SEM. The sample size for each 
experiment is included in the figure legends. 
 
Data and Software Availability 
See above Ribosome profiling and data processing. The accession numbers for all new 
RNA-sequencing data and ribosome-profiling data reported in this manuscript will be 














CHAPTER III:  POST-TRANSCRIPTIONAL REGULATION 




RNA binding proteins (RBPs) are emerging as critical regulators of intestinal 
development and cancer. IMP1 (IGF2 mRNA Binding Protein 1) hypomorphic mice 
exhibit severe intestinal growth defects, yet it’s role in adult epithelium is unclear. We 
investigated the mechanistic contribution of epithelial IMP1 to intestinal homeostasis and 
repair. We evaluated IMP1 expression in Crohn’s disease patients followed by unbiased 
ribosome profiling in IMP1 knockout cells. Concurrently, we evaluated mice with 
intestinal epithelial-specific Imp1 deletion (Imp1ΔIEC) following dextran sodium sulfate 
(DSS)-colitis. Based on ribosome profiling data, evaluated autophagy in Imp1ΔIEC mice, 
as well as in silico and in vitro approaches to determine direct protein:RNA interactions. 
Finally, we analyzed the consequence of genetic deletion of essential autophagy protein, 
Atg7, in Imp1ΔIEC mice using colitis and irradiation models. IMP1 was upregulated 
robustly in Crohn’s disease patients and Imp1 loss lessened DSS-colitis severity. 
Unbiased ribosome-profiling revealed that IMP1 may coordinate translation of multiple 
pathways important for intestinal homeostasis, including autophagy, which we verified by 
western blotting. Mechanistically, we found evidence for increased autophagy flux in 
Imp1ΔIEC mice, reinforced through in silico and biochemical analyses revealing direct 
binding of IMP1 to autophagy transcripts. Finally, we found genetic deletion of Atg7 
reversed the phenotype observed in DSS- or irradiation-challenged Imp1ΔIEC mice. IMP1 
acts as a post-transcriptional regulator of gut epithelial repair post-colitis and irradiation, 
in part through modulation of autophagy. This study provides a new perspective on post-
transcriptional regulation of autophagy as a contributing factor to the pathogenesis of 
inflammatory bowel disease. 
 
Keywords: RNA binding protein; IMP1; ribosome profiling; colitis; autophagy 
Transcript Profiling: GEO link 
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Introduction 
Intestinal epithelium maintains its integrity through orchestration of self-renewal, 
proliferation, differentiation, and cell death during homeostasis and in response to stress. 
The rapidity with which intestinal epithelium must respond to environmental stressors 
suggests a necessity for multiple layers of gene regulation. RNA binding proteins (RBPs) 
have emerged as critical regulators of intestinal proliferation and stem cell dynamics 
(Madison et al. 2013a; Li et al. 2015; Madison et al. 2015; Tu et al. 2015; Wang et al. 
2015a; Yousefi et al. 2016). IGF2 mRNA-binding protein 1 (IMP1) is a RBP with primary 
roles in mRNA trafficking, localization, and stability. Target mRNAs of IMP1 (also called 
IGF2BP1, CRD-BP, ZBP1) include IGF2, ACTB, MYC, H19, CD44, GLI1 and PTGS2 
(Leeds et al. 1997; Ross et al. 1997; Nielsen et al. 1999; Runge et al. 2000; Lemm and 
Ross 2002; Vikesaa et al. 2006; Noubissi et al. 2009; Manieri et al. 2012). In vitro 
studies demonstrate that IMP1 forms stable complexes with its target mRNAs, confining 
these transcripts to ribonucleoprotein particles (RNPs) and stabilizing mRNA or inhibiting 
translation (Bernstein et al. 1992; Huttelmaier et al. 2005; Noubissi et al. 2006; Stohr et 
al. 2006; Vikesaa et al. 2006; Gu et al. 2008; Elcheva et al. 2009; Noubissi et al. 2009; 
Weidensdorfer et al. 2009; Stohr et al. 2012). IMP1 also plays a functional role in mRNA 
transport to aid in various cellular processes, including movement and polarity (Vikesaa 
et al. 2006; Gu et al. 2012). Finally, PAR-CLIP and eCLIP studies have identified a 
myriad of IMP1 targets, providing important insight into the diverse and context-specific 
roles of IMP1 via regulation of specific transcripts or transcript groups (Hafner et al. 
2010; Conway et al. 2016).  
In mice, Imp1 is expressed in the small intestine and colon during embryonic 
development through postnatal day 12 and at low levels during adulthood (Hansen et al. 
2004). Imp1 hypomorphic mice exhibit dwarfism, intestinal defects and perinatal lethality 
(Hansen et al. 2004; Fakhraldeen et al. 2015). Recent studies in the fetal brain implicate 
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Imp1 as a regulator of differentiation of stem/progenitor cells, where Imp1 deletion leads 
to neural stem cell depletion (Nishino et al. 2013). In adult mouse colon, IMP1 is 
expressed in the epithelial crypt base and in mesenchymal cells following injury 
(Dimitriadis et al. 2007a; Manieri et al. 2012). Our prior published studies demonstrated 
that IMP1 may promote or suppress colon tumorigenesis based upon its expression and 
function in the epithelial or mesenchymal compartments, underscoring the notion that 
IMP1 may exhibit opposing effects in different contexts (Hamilton et al. 2013; Hamilton 
et al. 2015). Taken together, in vivo studies suggest IMP1 as a key regulator of 
development and cancer, potentially via regulation of stem/progenitor cell maintenance 
(Degrauwe et al. 2016b).  
Finally, prior reports have suggested a role for IMP1 in cellular stress response. 
Studies of the IMP1 chicken orthologue, ZBP1, revealed an essential role in the 
integrated stress response (ISR) via differential regulation of mRNA fates in non-
stressed versus stressed cells (Stohr et al. 2006). Characterization of IMP1 RNP 
granules in vitro revealed enrichment of mRNAs encoding proteins involved in the 
secretory pathway, ER stress, and ubiquitin-dependent metabolism (Jonson et al. 2007). 
Despite its considerable importance in normal development and its role in coordinating 
cellular stress, the specific functional roles of IMP1 in adult tissues have yet to be 
elucidated in vivo. In the present study, we tested the hypothesis that IMP1 functions as 
a regulator of epithelial response to damage in adult tissues. 
Results 
IMP1 is upregulated in adult and pediatric Crohn’s disease patients  
Based upon prior studies, we reasoned that IMP1 may play a role during damage 
or stress conditions in the gut. In whole tissue biopsies from adult Crohn’s disease 
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patients (Table 1), we observed a >5-fold increase in IMP1 compared to control patients 
(1±0.12 versus 5.3±1.81, Figure 12A). This was confirmed via IMP1 
immunohistochemistry, where we observed both epithelial and stromal IMP1 staining in 
adult Crohn’s disease patients (Figure 12B). Consistent with these findings, analysis of 
published RISK RNA-sequencing data from pediatric inflammatory bowel disease (IBD) 
patients revealed that IMP1 is upregulated significantly compared to control patients, 
and that this effect is specific to IMP1 (i.e. other distinct isoforms, IMP2 and IMP3, are 
not changed; Figure 12C) (Haberman et al. 2014). 
 
Mice with intestinal epithelial cell deletion of Imp1 exhibit increased 
recovery following colitis 
 We next evaluated the functional consequence of Imp1 deletion during chronic 
colitis using VillinCre; Imp1fl/fl mice (Imp1ΔIEC mice; Supplementary Figure 7A). Imp1ΔIEC 
mice lost significantly less weight following 3 cycles of dextran sodium sulfate (DSS) 
compared to controls (Imp1fl/fl, denoted as Imp1WT; Figure 13A). Imp1ΔIEC mice exhibited 
an overall decrease in colitis score, hyperplasia, inflammation, and mononuclear cell 
score (Figure 13B-F). In addition, cytokine expression was decreased in Imp1ΔIEC mice 
(Figure 13G).  Imp1ΔIEC mice further displayed a modest decrease colon shortening 
compared to controls (Supplementary Figure 7B). Together, these observations suggest 
that Imp1 loss in intestinal epithelium may promote recovery from damage in the setting 
of DSS-colitis. 
 
IMP1 knockout reveals global changes in translation 
 Transcriptome-wide approaches provide a global snapshot of transcript 
abundance within a given context; however, the functional effects of RBPs are not 
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captured fully by RNA-sequencing alone. To define the putative molecular basis for 
phenotypic differences between Imp1ΔIEC and control mice, we examined the effect of 
IMP1 loss upon translation efficiency. Due to technical challenges in performing 
ribosome-profiling in vivo, we utilized CRISPR-mediated IMP1 deletion in the SW480 
colorectal cancer cell line to evaluate “translatome”-wide effects of IMP1 loss (Figure 
14A; Supplementary Figure 8A&B). Following deep sequencing to compare total RNA 
abundance in SW480 cells with and without IMP1, RNA fragments protected by bound 
ribosomes were sequenced to define actively translating mRNAs ( Data deposited in 
GEO (GSE112305) [NCBI tracking system #18999297]). We found that IMP1 loss 
affected gene expression on both transcriptional and translational levels. Of the 10043 
genes analyzed, we saw no change in RNA level or ribosome binding in 7386 genes 
(Figure 14B). 642 transcripts were exclusively differentially regulated at the transcription 
level whereas 1264 genes were only differentially regulated at the translational level. 
Furthermore, in 28 genes, translation direction was completely antagonistic to 
transcription, whereas translation reinforced transcriptional direction in 60 genes (Figure 
14B). Additionally, in 663 genes translation acted as a buffering mechanism (McManus 
et al. 2014), whereby protein levels remain constant despite changes in mRNA levels. 
 Translational efficiency (TE) of a gene is defined as the ratio of abundance in 
ribosome protected fragments (RPF) to that of total mRNA abundance for a gene (Zhong 
et al. 2017). We compared TE changes between the two genotypes and observed 
differential TE for 1469 genes (Figure 14C). Pathway enrichment analysis for TE genes 
(Chen et al. 2009) differentially expressed in cells with IMP1 deletion revealed a 
significant representation of pathways linked to cell cycle, gene expression and RNA 
processing, post-translational modification, autophagy, and metabolism (Figure 14D). 
Enhanced TE of these pathways suggest a post-transcriptional program directed by 
IMP1 that may underlie the protective or regenerative effects observed in Imp1ΔIEC mice. 
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Mice with Imp1 loss exhibit morphological changes in Paneth cells and 
enhanced autophagy 
Evidence in Imp1 hypomorphic mice, which express 20% of wild type Imp1, suggests 
that its expression is critical for normal growth and development, as these mice exhibit 
high perinatal mortality and morphological defects in intestine epithelium (Hansen et al. 
2004; Fakhraldeen et al. 2015). We observe no gross phenotypic effects in Imp1ΔIEC 
mice, suggesting that intestinal epithelial IMP1 is dispensable during homeostasis 
(Supplementary 9A). We analyzed the number and morphology of differentiated 
epithelial cell types and although there was no difference in total Paneth, goblet, or 
enteroendocrine cell numbers between genotypes (Supplementary Figure 9B, C), diffuse 
lysozyme staining was apparent in Paneth cells of Imp1ΔIEC mice (Figure 15A&B). As 
autophagy gene mutations have been associated with Paneth cell granule defects in 
Crohn’s disease patients (Liu et al. 2014b; VanDussen et al. 2014; Liu et al. 2016; Liu et 
al. 2017; Stappenbeck and McGovern 2017), we evaluated autophagy in Imp1ΔIEC mice. 
Freshly isolated, live crypt cells stained with the cationic amphiphilic tracer dye CytoID, 
which incorporates into autophagic structures, revealed an increase in basal autophagic 
vesicle content in Imp1ΔIEC mice via flow cytometry (Fig. 15C). Importantly, we validated 
CytoID as a tool to measure autophagy using Atg7ΔIEC mice (Supplementary Figure 10A, 
B). Ultrastructural analysis of crypts via transmission electron microscopy (TEM) 
revealed an increase in small, electron-dense lysozyme granules within areas of 
electron-lucent halos in Imp1ΔIEC mice compared to controls (Fig. 15E). As an additional 
measure of autophagy, we performed western blotting for cleaved LC3 in freshly isolated 
Imp1ΔIEC colon and jejunum crypt cells. A shift from the upper to lower LC3 band 
suggested enhanced autophagic vesicle content in Imp1ΔIEC mice (Figure 15E; 
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Supplementary Figure 9D). Furthermore, a concurrent decrease in autophagy cargo-
associated protein p62 in Imp1ΔIEC colon crypts, indicted increased autophagy flux 
(Figure 15E).  
 To confirm a direct role for IMP1 knockdown to induce autophagy, we evaluated 
Caco2 cells transfected with IMP1 siRNA and observed a robust increase in LC3-I/LC3-II 
(Figure 15F). Finally, in order to determine if changes in autophagy are maintained ex 
vivo, Imp1ΔIEC and Imp1WT enteroids were treated with the lysosomal inhibitor 
chloroquine (CQ) and evaluated for CytoID puncta formation. Active autophagic flux is 
signified by an accumulation of CytoID–stained puncta upon CQ treatment, which we 
observed in both Imp1ΔIEC and Imp1WT mice (Figure 15G). Intriguingly, we noted a 
broader CytoID staining pattern (not restricted to Paneth cells) in Imp1ΔIEC mice. As such, 
we performed gene expression analysis for Imp1 in Lgr5+ and Paneth (CD24/cKit/SSC 
high) cells sorted from Lgr5-eGFP-IRES-CreERT2 mouse crypt epithelium. We observed 
that Imp1 is enriched in both Lgr5+ and Paneth cells compared to unsorted crypts 
(Figure 15H). 
 
Enhanced recovery from colitis in Imp1ΔIEC mice is reversed with genetic 
deletion of Atg7  
 Based upon our data that Imp1ΔIEC mice exhibited decreased inflammation and 
colitis during chronic DSS, we aimed to determine if Imp1ΔIEC mice fare better during 
acute colitis. Both Imp1WT and Imp1ΔIEC mice exhibited significant weight loss following 
five days of DSS treatment, but Imp1ΔIEC mice began to recover weight, whereas Imp1WT 
mice required sacrifice due to weight loss (Figure 16A). Acute DSS-treated Imp1ΔIEC 
mice exhibited significantly lower total colitis and epithelial loss scores compared to 
controls (Figure 16B, C). Prior studies suggest enhanced susceptibility to colitis in mice 
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with genetic deletion of autophagy (Tsuboi et al. 2015). ATG7 is an essential component 
of the ATG conjugation system and is critical for early autophagosome formation 
(Komatsu et al. 2005). In addition, prior studies of intestinal epithelial-specific Atg7 
deletion demonstrated loss of autophagic vacuoles via TEM analysis and a phenotype 
similar to that of intestinal epithelial-specific knockout of the autophagy genes Atg16L1 
or Atg5 (Cadwell et al. 2009; Adolph et al. 2013). To evaluate the relative contribution of 
enhanced autophagy to the phenotype in Imp1ΔIEC mice, we generated Imp1ΔIEC mice 
with genetic deletion of autophagy using Atg7-floxed alleles (Imp1ΔIECAtg7ΔIEC). 
Imp1ΔIECAtg7ΔIEC mice lost weight and became moribund more rapidly than Imp1WT and 
Imp1ΔIEC mice, requiring sacrifice prior to the recovery period (Figure 16A). Thus, 
autophagy loss offsets the beneficial effect of Imp1 loss during acute colitis.  
 We next evaluated whether Imp1 loss could promote enhanced recovery in a 
second damage/stress model. We challenged Imp1ΔIEC mice with 12Gy whole body 
irradiation and evaluated tissue regeneration via quantification of EdU+ regenerative 
microcolonies. Imp1ΔIEC mice loss less weight and exhibited a significant increase in 
number of EdU+ microcolonies compared to Imp1WT mice (Fig. 16D, E). Imp1ΔIECAtg7ΔIEC 
mice exhibited more weight loss and fewer regenerating microcolonies than Imp1ΔIEC 
mice, suggesting that Atg7 deletion reversed the beneficial effects of Imp1 loss in this 
context. Taken together, these data suggest that IMP1 can regulate the autophagy 
pathway during homeostasis and in two injury models.  
 
IMP1 interacts with autophagy transcripts 
 One way in which RBPs regulate post-transcriptional gene expression is via 
direct binding of target transcripts. We have demonstrated that Imp1 loss 1) enhances 
translation efficiency of genes in the autophagy pathway (Figure 14D), and 2) leads to 
increased LC3 protein expression (Figure 15E, F; Supplementary Figure 9D). We 
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therefore evaluated direct binding of IMP1 to autophagy transcripts. We first performed 
in silico analyses to assess binding propensities of IMP1 for autophagy transcripts using 
catRAPID, which predicts RNA:protein interactions based upon nucleotide and 
polypeptide sequences as well as physicochemical properties (Cirillo et al. 2016). These 
analyses predicted binding of IMP1 to BECN1, MAP1LC3B and ATG3 transcripts (Figure 
17A), as well as positive control ACTB.  Lower relative binding scores were predicted for 
ATG16L1, ATG7, and ATG5. This algorithm predicted no binding to negative targets 
TNFRSF1B and ITGA7. We next evaluated published eCLIP data (Conway et al. 2016) 
in human pluripotent stem cells for the same autophagy transcripts and found a 
signification correlation between catRAPID-predicted binding and eCLIP binding (r = 
0.9838465 Pearson correlation coefficient, Figure 17B). To confirm IMP1 binding to 
these targets, we performed ribonucleoprotein (RNP)-immunoprecipitation with 
antibodies to endogenous IMP1 in Caco2 cells. Previously confirmed IMP1 targets 
ACTN and PTGS2 and non-target TNFRSF1B were used as positive and negative 
controls, respectively. We observed significant binding enrichment in autophagy genes 
MAP1LC3B and ATG3 with IMP1 (Figure 17C, Supplementary Figure 11A). ATG7, 
BECN1, and ATG5 all demonstrated enriched binding similar to PTGS2, which was 
confirmed as an IMP1 binding target in prior published studies (Manieri et al. 2012). As 
both ATG3 and ATG5 were enriched in ribosome-profiling, in silico predictions, and in 
vivo binding, we evaluated protein levels in crypts isolated from Imp1ΔIEC mice. We 
observed increased Atg3 and Atg5 in Imp1ΔIEC colon epithelium compared to controls, 
suggesting that IMP1 may directly affect protein levels of key components in the 
autophagy pathway (Figure 17D).  In addition, in silico analysis of individual transcripts 
predicted binding of IMP1 to 5’ UTRs of ATG3 and ATG5 (Supplementary Figure 11B, 
C) Taken together, we demonstrate via three independent methods that IMP1 binds 
directly to specific autophagy transcripts required early in the autophagy cascade, 
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suggesting direct binding as one mechanism by which IMP1 regulates the autophagy 
pathway during homeostasis. 
Discussion 
In the current study, we describe a new role for the RBP IMP1 to regulate 
homeostasis in intestinal/colonic epithelium. We demonstrate that IMP1 is upregulated in 
Crohn’s disease patients and that Imp1 loss leads to enhanced repair following damage 
in vivo. Unbiased and phenotypic data revealed a mechanistic relationship between 
IMP1 and the autophagy pathway, underscoring post-transcriptional regulation as an 
additional layer of gut epithelial response to stress. Prior in vivo studies have implicated 
IMP1’s critical role in development, and we and others have demonstrated diverse roles 
for IMP1 in cancer (Hansen et al. 2004; Hamilton et al. 2013; Hamilton et al. 2015). The 
present study is the first to uncover in vivo mechanisms for IMP1 during homeostasis. 
IMP1-containing RNP granules are localized around the nucleus and in cellular 
projections, containing mRNAs representing up to 3% of the transcriptome in HEK293 
cells. These granules contain significant enrichment of transcripts encoding proteins 
involved in ER quality control, Golgi, and secretory vesicles, consistent with our finding 
that alterations in IMP1 affect the autophagy pathway (Jonson et al. 2007). While the 
functional roles of autophagy are context-dependent, the regulation of autophagy itself is 
an emerging field of investigation. Interplay between autophagy, homeostasis, and 
disease in the gut, as well as the associated regulatory cascades, may have important 
potential therapeutic implications as well. 
In IECs, autophagy contributes to microbial handling through packaging and 
secretion of antimicrobial peptides by Paneth cells. Independent groups have 
demonstrated that mice with Atg16l1 gene mutations are more sensitive to colitis or 
infection, exhibit increased serum IL-1β and IL-18, and display diffuse lysozyme staining 
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in Paneth cells (Cadwell et al. 2008; Saitoh et al. 2008; Cadwell et al. 2009; Matsuzawa-
Ishimoto et al. 2017; Burger et al. 2018; Pott et al. 2018). In addition, several recent 
studies revealed that autophagy genotype-phenotype associations may be used to sub-
classify Crohn’s patients (Rioux et al. 2007; VanDussen et al. 2014; Liu et al. 2016). 
Evaluation of Imp1ΔIEC mice revealed diffuse lysozyme staining. Intriguingly, we found 
evidence of enhanced autophagy flux in these mice, suggesting that additional pathways 
may be altered in Imp1ΔIEC mice.  Recent studies by Bel et al. demonstrated that Paneth 
cells secrete lysozyme via secretory autophagy during bacterial infection through 
activation of DC-ILC3 circuit (Bel et al. 2017); however, it remains unclear whether 
secretory autophagy is engaged as a homeostatic mechanism. As such, it would be 
interesting to determine whether IMP1 may regulate Paneth cell secretory autophagy in 
future studies. While a role for autophagy in Paneth cells is reasonably understood, 
other crypt cells, including crypt base columnar stem cells, may rely upon the autophagy 
stress response for survival. In support of this notion, deletion of Atg5 in all IECs except 
Paneth cells (using Ah-Cre) revealed impaired recovery after irradiation, underscoring 
Paneth cell-independent roles of autophagy in the gut (Asano et al. 2017). Our 
observation that Imp1 is expressed in both Lgr5+ and Paneth cells suggests a broader 
role for Imp1 than in Paneth cells.  
The levels of functional regulation of autophagy include transcriptional (e.g. 
TP53, STAT3 and NFκB), posttranscriptional (via miRNAs), and posttranslational 
(phosphorylation, ubiquitination and acetylation) (Copetti et al. 2009; Yee et al. 2009; 
Lipinski et al. 2010; Feng et al. 2015; Jing et al. 2015). To date, autophagy regulation by 
RBPs autophagy is largely unexplored. Recently, the Dhh1 mRNA decapping regulator 
and its mammalian homolog DDX6 were implicated as repressors of autophagy through 
direct modulation of LC3 transcript stability (Hu et al. 2015). This supports the premise 
that while autophagy activation is beneficial for cellular response to stress, post-
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transcriptional repressors may play a critical role in attenuating autophagy to prevent 
prolonged activation. Our biochemical data suggest that IMP1 may represent a new 
post-transcriptional modulator of the autophagy pathway, acting as an “autophagy 
rheostat” in intestinal/colonic epithelium (Figure 18). IMP1 binds to and regulates the fate 
of target transcripts; in part via binding to different mRNA regions. Early biochemical 
studies demonstrated IMP1 binding to the 5′ UTR of the translationally regulated IGF-II 
leader 3 mRNA, leading to translational repression (Nielsen et al. 1999). More recently, 
IMP1 was demonstrated to bind primarily to 3’UTRs at the region-level (Conway et al. 
2016). Our finding that IMP1 is predicted to bind to 5’ UTRs of autophagy transcripts 
supports the model whereby IMP1 may bind to and repress the translation of pivotal 
autophagy transcripts.  
Finally, our studies evaluating direct binding of IMP1 to autophagy mRNAs may 
lay the foundation for development of new therapies to selectively modulate autophagy 
(Kuo et al. 2015; Hooper et al. 2016). Indeed, it is feasible to identify small molecule 
inhibitors to disrupt IMP1 interactions with specific mRNA targets, permitting specific 
modulation of a desired pathway without disrupting other important functional roles 
(Mahapatra et al. 2014). What remains unknown are the upstream signaling pathways 
that may determine the fate of IMP1-bound transcripts (stabilization versus degradation) 
within specific contexts, as well as the ability of specific sequence motifs to confer IMP1 
target specificity for autophagy (or other) transcripts. In addition, the role for cooperation 
between IMP1 and microRNAs to elicit specific phenotypes, including effects on 
autophagy, remain to be determined (Elcheva et al. 2009). In summary, the current 
study reveals that IMP1 may function as a mediator of homeostasis by regulating 
autophagy in gut epithelial cells. More broadly, these studies underscore the importance 
of evaluating post-transcriptional contributions to gastrointestinal homeostasis and 
disease.  
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Figures and Figure legends 
Figure 12: IMP1 is upregulated in adult and pediatric Crohn’s disease patients  
 
A.  qPCR analysis for IMP1 expression in colon biopsy samples from adult Crohn’s 
disease (CD) patients. IMP1 expression is >5 fold higher in CD samples (5.314 ± 1.807, 
n=8) as compared to control samples (1 ± 0.1245, n=7). B. Representative 
immunohistochemistry demonstrating IMP1 expression in colon biopsy samples from CD 
patients and normal adults. IMP1 expression is higher in CD samples (Scale bars = 
500m). C. Differential gene expression analysis of pediatric CD patient colon samples 
(n=180) show increased (>4 fold) IMP1 expression as compared to non-inflammatory 
bowel disease (IBD) (n=43) pediatric samples. (All data are expressed as mean ± SEM. 
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*, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001 by ordinary one-way ANOVA test 




Figure 13: Mice with intestinal epithelial cell deletion of Imp1 exhibit increased 
recovery following colitis 
 
A. Mice were given 3 cycles of 2.5% DSS in drinking water for 5 days followed by a 
week of recovery. Mice with Imp1 deletion lost significantly less weight as compared to 
controls at day 36. B. Representative H&E pictures of Imp1WT and Imp1ΔIEC mice at day 
36 after chronic DSS treatment (Scale bars = 500m).  C. Imp1ΔIEC mice show 
significantly less total colitis (7.769 ± 0.4824, n=13; As scored blinded by a pathologist) 
as compared to Imp1WT mice (9.714 ± 0.8371, n=7). D. Imp1ΔIEC mice show significantly 
less hyperplasia (1.615 ± 0.1404, n=13) as compared to Imp1WT mice (2.286 ± 0.2857, 
n=7). E. Imp1ΔIEC mice show significantly less inflammation score (6.231 ± 0.3608, n=13) 
as compared to Imp1WT mice (8 ± 0.6901, n=7). F. Imp1ΔIEC mice show significantly less 
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mono-nuclear cell infiltration (1.077 ± 0.076, n=13;) as compared to Imp1WT mice (1.714 
± 0.2857, n=7). G. qPCR data showing expression of different cytokines in colon 
epithelium of Imp1WT and Imp1ΔIEC mice at day 36 after chronic DSS treatment.  (All data 
are expressed as mean ± SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001 




Figure 14: IMP1 knockout reveals global changes in the “translatome” 
 
A. Simplistic schematic of ribosome profiling technique. B. Scatterplot of differential 
expression between SW480 cells with and without IMP1 deletion. The log2 fold change 
between ribosome-bound RNAs (ribosome protected fragments, or RPF) and total 
mRNA is plotted. The plot indicates that IMP1 regulates both mRNA abundance and 
translation. C. Scatterplot of genes with significant (in blue) differential translational 
efficiencies between SW480 cells with and without IMP1 deletion. Translation 
efficiencies of transcripts are calculated as the ratio of reads of ribosome-protected 
fragments to the reads in total mRNA abundance. D. Pathway analysis using Toppgene 
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gene enrichment analysis software of differentially expressed genes from C to define 




Figure 15: Mice with Imp1 loss exhibit morphological changes in Paneth cells and 
enhanced autophagy 
 
A. Paneth cells from Imp1WT and Imp1ΔIEC mice were evaluated histologically using IF for 
lysozyme (LYZ). E-cadherin (ECAD) staining was used to demarcate individual epithelial 
cells. Note presence of diffuse lysozyme staining in Imp1ΔIEC mice. B. Published 
lysozyme scoring was utilized to evaluate specific Paneth cell phenotypes. Imp1ΔIEC mice 
exhibit a significant shift from normal to diffuse lysozyme phenotype (n= 4 mice per 
genotype). C. Live cell staining of autophagic structures with the cationic amphiphilic 
tracer dye CytoID indicated a significant increase in autophagic vesicles in crypts from 
Imp1ΔIEC mice (n=8) compared to Imp1WT mice (n= 7) using flow cytometry. D. 
Transmission electron microscopy revealed an abundance of small, electron dense 
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granules in Imp1ΔIEC mice. E. To confirm a direct role for IMP1 knockdown to induce 
autophagy, we evaluated epithelial cells from colon in Imp1WT and Imp1ΔIEC mice. This 
confirmed a robust increase in LC3 and decrease in p62, which together indicate 
enhanced flux. Blots are representative of 3 independent experiments. F. Caco2 cells 
transfected with IMP1 siRNA demonstrated a robust increase in LC3-I/LC3-II indicating 
enhanced flux. Blots are representative of 3 independent experiments. G. Crypt enteroid 
cultures from Imp1WT and Imp1ΔIEC mice were treated with the autophagy inhibitor 
chloroquine (CQ) for 3 hours and then stained with CytoID to evaluate autophagy flux, 
where increased CytoID puncta with CQ treatment represents active flux. There was a 
modest increase in basal CytoID in Imp1ΔIEC enteroids compared to controls, as seen 
with FACS analysis of isolated crypts from Imp1ΔIEC mice in C, and both genotypes 
exhibited an increase in CytoID puncta with CQ treatment. H. qPCR for Imp1 expression 
in Lgr5+ and Paneth (CD24/cKit/SSC high) cells sorted from Lgr5-eGFP-IRES-CreERT2 
mouse crypt epithelium. (All data are expressed as mean ± SEM. *, p < 0.05; **, p < 




Figure 16: Genetic deletion of Atg7 reverses the Imp1ΔIEC phenotype during colitis 
 
A. Mice were given 5% DSS in drinking water for 5 days followed by 4 days of recovery. 
Mice with Imp1 deletion lost significantly less weight as compared to controls. 
Imp1ΔIECAtg7ΔIEC mice lost weight and became moribund more rapidly than Imp1WT and 
Imp1ΔIEC mice, requiring sacrifice prior to the recovery period. B. Imp1ΔIEC mice show 
significantly less total colitis (11.14 ± 1.933, n=7; As scored blinded by a pathologist) as 
compared to Imp1WT mice (17.75 ± 2.144, n=8). C. Imp1ΔIEC mice show significantly less 
epithelial loss (5.286 ± 0.865, n=7) as compared to Imp1WT mice (9.375 ± 1.375, n=8). D. 
Imp1 deletion confers protective effects following irradiation, which is reversed in the 
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context of Atg7 deletion. Imp1ΔIEC mice lost significantly less weight at sacrifice following 
irradiation than controls (18.83 ±0.98% in Imp1ΔIEC mice(n=12) versus 23.34 ±0.56% 
mean weight loss in controls (n=14). This phenotype was abrogated in Imp1ΔIECAtg7ΔIEC 
mice (23.5±1.05% mean weight loss, n=5). For untreated animals, there was no 
significant difference in mean body weights between groups (not shown). E&F. Analysis 
of EdU+, S-phase cells revealed similar staining in all non-IR mice; however, there was a 
robust increase in EdU+ regenerative crypt foci at 4 days following irradiation in Imp1ΔIEC 
mice compared to Imp1WT mice, and this effect was abolished in Imp1ΔIECAtg7ΔIEC mice 
(n=4 mice per genotype, 20-30 HPF per animal).(All data are expressed as mean ± 
SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001 by ordinary one-way 




Figure 17: IMP1 directly binds autophagy mRNAs.  
 
We utilized computational predictions, analyses of published CLIP-Seq data and 
ribonucleoprotein-immunoprecipitation (RIP) to identify direct interactions between IMP1 
and autophagy transcripts. A. catRAPID Transcript Score. For each predicted transcript, 
we measured the IMP1 interaction propensity with respect to the negative control IgG. 
Negative targets (ITGA7 and TNFRSF1B) were also evaluated. B. We retrieved CLIP 
scores from published eCLIP data against the same set of autophagy-related transcripts 
analyzed in A and found a strong correlation between catRAPID scores and eCLIP data 
(r =0.9838465 Pearson correlation coefficient). The CLIP data scores were calculated as 
total number of reads corresponding to the transcript divided by the length of the 
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different isoforms. C. We evaluated binding of endogenous IMP1 to autophagy 
transcripts using RIP assays in Caco2 cells. Specific enrichment of IMP1 was confirmed 
by IP with either IMP1 or control IgG antibodies followed by western blot for IMP1. 
Enrichment of target transcripts over control is represented relative to negative target, 
TNFRSF1B. Positive controls were PTGS2 and ACTB. vs. negative target by 1-way 
ANOVA. n=3 independent experiments. D. Representative western blot showing 
upregulation of Atg3 and Atg5 in colon epithelium of Imp1ΔIEC mice as compared to 
controls. (All data are expressed as mean ± SEM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; 




Figure 18: Model for IMP1 modulation of intestinal epithelial homeostasis.  
 
Schematic depicts proposed model for IMP1 function during homeostasis, where IMP1 
binds autophagy transcripts and represses their translation post-challenge in order to 





Supplementary Figure 7 
 
A. Schematic showing the chronic DSS experimental protocol. B. The colon lengths of 
Imp1WT and Imp1ΔIEC mice showed no significant difference following chronic DSS. 
 
Supplementary Figure 8 
 
A. SW480 cells with RFP expression following incorporation of HDR plasmid after 
CRISPR transfection. B. Representative western blot showing complete IMP1 deletion in 
SW480 cells after CRISPR transfection. 
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Supplementary Figure 9 
 
A. Representative H&E sections showing no overt morphological differences between 
the small intestine and colon in Imp1WT and Imp1ΔIEC mice. B. Quantification of Paneth 
cell number shows no differences between Imp1WT and Imp1ΔIEC mice. C. Representative 
immunofluorescence staining showing no differences in goblet cells (Muc2+) or 
enteroendocrine cells (Chromagranin+) between Imp1WT and Imp1ΔIEC mice. D. Western 
blot for LC3-I/LC3-II in isolated crypts from Imp1WT and Imp1ΔIEC mice revealed an 
increase in LC3 indicating increased autophagy flux. (n= 3 mice per genotype) 
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Supplementary Figure 10 
 
A. Representative western blot comparing Atg7ΔIEC mice and controls. Atg7ΔIEC mice 
show no ATG7 expression and decreased autophagic flux indicated by increased p62 
and no LC3-II levels. B. Mean fluorescence intensity of CytoID is significantly reduced in 




Supplementary Figure 11 
 
We evaluated binding of endogenous IMP1 to autophagy transcripts using RIP assays in 
Caco2 cells. A. Specific enrichment of IMP1 was confirmed by IP with either IMP1 or 
control IgG antibodies followed by Western blot for IMP1. Blot is representative of 3 
independent experiments. B, C. CatRAPID plots show the binding propensity along the 
isoform sequence for ATG3 and ATG5. Key: 5’ UTRs in red, ORFs in blue and 3’UTRs 
in green. 
Materials and methods 
Human samples 
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Frozen colon tissue and FFPE samples from adult normal and Crohn’s patients were 
obtained from the Cooperative Human Tissue Network (CHTN) via the University of 
Pennsylvania Center for Molecular Studies in Digestive and Liver Diseases Molecular 
Biology and Gene Expression Core. RNA was extracted from frozen tissue using Trizol 
(Thermo Fisher, Waltham, MA). Publicly available RNA-sequencing data from the RISK 
cohort of pediatric ileal Crohn’s (Haberman et al. 2014) was evaluated for differential 
expression of IGF2BP1 (IMP1), IMP2, and IMP3. Sequenced reads were trimmed using 
Trim Galore! (version 0.4.4), and aligned to the GRCh37 reference genome using STAR, 
version 2.5.3a. Uniquely mapped reads were quantified by Ensembl gene IDs using 
featureCounts from Subread version 1.6.0. Lowly or unexpressed genes were removed 
from the analysis if they showed less than 2 counts per million in less than 5 samples 
across all conditions. Read counts were transformed with voom and evaluated for 
differential expression using limma. 
 
Animals 
Mice were cared for in accordance with University Laboratory Animal Resources 
requirements under an Institutional Animal Care and Use Committee-approved protocol. 
VillinCre;Imp1-floxed (Imp1ΔIEC) mice were generated previously (Hamilton et al. 2013) 
and maintained on a C57Bl/6 background. Control mice had floxed, intact alleles 
(Imp1WT ). Male and female mice were both used at 8-12 weeks. Lgr5-EGFP-IRES-
creERT2 mice were purchased from Jackson Laboratories. Atg7-floxed mice were kindly 
provided by RIKEN BRC through National Bio-Resource Project of MEXT, Japan 
(Komatsu et al. 2005). Mice were housed in specific pathogen-free conditions and fed 
standard, irradiated chow and water ad libitum. 
Co-housed control and experimental genotypes were randomized at weaning 
across multiple cages. Mice were given 2.5% dextran sodium sulfate (40,000-50,000 
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kDa molecular weight; Affymetrix CAS 9011-18-1) in drinking water for chronic (Figure 
S1) or 5% DSS for acute colitis (Figure 5). For irradiation experiments, animals were 
given a single dose of 12Gy using Gammacell 40 Cesium 137 Irradiation Unit. Mouse 
jejunum was analyzed for irradiation experiments. During all experiments, body weights 
were recorded daily, and mice were euthanized before losing a maximum of 25% total 
body weight. Histological scoring was performed blinded by expert veterinary pathologist 
Enrico Radaelli according to published protocols (Washington et al. 2013). Sample sizes 
were determined based upon the investigators’ prior experience with specific models 
(KEH, GDW).  
 
Ribosome profiling 
Ribosome profiling libraries from 3 pooled cell culture plates were prepared using a 
standard protocol (McGlincy and Ingolia 2017), with minor modifications. Separate 5’ 
and 3’ linkers were ligated to the RNA-fragment instead of 3’ linker followed by 
circularization (Subtelny et al. 2014). 5’ linkers contained 4 random nt unique molecular 
identifier (UMI) similar to a 5 nt UMI in 3’ linkers. During size-selection, we restricted the 
footprint lengths to 18-34 nts. Matched RNA-seq libraries were prepared using RNA that 
was randomly fragmentation by incubating for 15 min at 95C with in 1 mM EDTA, 6 mM 
Na2CO3, 44 mM NaHCO3, pH 9.3. RNA-seq fragments were restricted to 18-50 nts. 
Ribosomal rRNA were removed from pooled RNA-seq and footprinting samples using 
RiboZero (Epicenter MRZH116). cDNA for the pooled library were PCR amplified for 15 
cycles. RNA-seq and footprinting reads were mapped to the human transcriptome using 




CytoID Autophagy Detection Kit (Enzo Life Sciences) was used to stain single cell 
suspensions of crypt-enriched intestinal epithelium (1:100 in DPBS supplemented with 
10% FBS at 37°C for 30 min) and co-stained with DAPI. Flow cytometry was performed 
using FACSCanto or LSR II cytometers (BD Biosciences) and FlowJo software (Tree 
Star). Unstained cells from each specimen were utilized to establish background 
fluorescence. The percent of CytoID-positive cells was determined in the live cell fraction 
(DAPI-negative). The geometric mean fluorescence intensity for live cells was 
determined for each specimen following subtraction of background fluorescence. Blinded 
scoring was utilized (KAW) 75, 76. Enteroids were passaged 1 day prior to assays in order 
to obtain equivalent plating densities. Three hours prior to imaging, 2 μg/ml CytoID and 2 
μg/ml Hoechst33342 (ENZO Life Science) were added in the medium and incubated at 
37°C for 3 hours. 120 μM of chloroquine (ENZO Life Science) was used. Enteroids were 
immediately analyzed using confocal microscopy ECLIPSE Ti (Nikon). Six to ten 
enteroids per mouse were analyzed across three mice per genotype (blinded, RM).  
 
catRAPID analyses 
We used the catRAPID fragment approach (Bellucci et al. 2011; Cirillo et al. 2013) to 
predict IMP1 binding to autophagy-related transcripts (i.e.: MAP1LC3B, ATG3, BECN1, 
ATG5, ATG16L1 and ATG7). ACTB and TNFRSF1B/ITGA7 were also included as 
positive and negative controls, respectively. In our analysis, we included different 
isoforms for each transcript, for a total of 25 different targets, including the positive and 




Given a transcript isoform , we used catRAPID uniform fragmentation to generate  
overlapping fragments that cover the entire sequence. The fragments  are then used 
to compute catRAPID interacting propensities with IMP1 and IgG (negative control). We 
define the interaction threshold
 
 as the highest interaction propensity score that IgG 
has with the  fragments generated from sequence : 
 
       
 (1) 
             
For every IMP1 interaction with fragments, we computed the normalized interaction  




              
 (2) 
 
Fragments with normalized interaction score  are predicted to interact with IMP1. 
The Isoform Score of each isoform  (Fig. S4A) is computed as the average 










q(ri ) = max
j
[p (p = IgG,r = ri, j )]
p '
p '(p = IMP1,r = ri, j ) = p(p = IMP1,r = ri, j )-q(ri ))
p ' > 0
Pi




We define the Transcript Score  (Fig. 5A) as a global interaction propensity of all 
isoforms belonging to a certain transcript. The Transcript Score is defined as the 
average of the Isoform Scores for all the isoforms analyzed for each transcript: 
 
,                  
(4)   




Applying unpaired, two-tailed student’s t-tests or 1-way ANOVA, with P <0.05 as 
statistically significant, determined statistical significance of comparisons between 
control and experimental conditions unless otherwise noted in the figures legends. For 
all analyses, unless noted otherwise, data from a minimum of three experiments are 
presented as mean ± standard error. Sample sizes for individual experiments, including 
biological and technical replicates, are described in each figure legend, as well as 





Human colon cancer cell line Caco2 (ATCC HTB-37) cells were obtained from ATCC, 
which provides STR authentication, within the past 18 months. Cells are tested for 
mycoplasma at least every 3 months. IMP1 siRNA (h) (Santa Cruz, sc-40694) or 
Silencer® Select Negative Control No. 1 siRNA (Thermo Fisher Scientific, 4390843) was 





13778075). IMP1 was deleted in SW480 cells (ATCC® CCL-228™) by co-transfecting 
cells with IMP1 CRISPR/Cas9 KO Plasmid (h) (Santa Cruz; sc-401703) and IMP-1 HDR 
Plasmid (h) (Santa Cruz ; sc-401703 HDR) followed by sorting and clonal expansion of 
RFP+ve cells. Knockout was verified by western blotting for IMP1.  
 
Histology 
Small intestines were fixed in 10% formalin, processed and paraffin-embedded. 
Immunofluorescence (IF) staining was performed using heat antigen-retrieval in citric 
acid buffer (pH 6.0) and staining with antibodies. 5-ethynyl-2´-deoxyuridine (EdU) 
staining was performed using Click-iT® EdU Alexa Fluor® 488 Imaging Kit (C10337) as 
per manufacturer’s protocol. For IMP1 IHC, blocking was performed using Animal-Free 
Blocker (Vector Laboratories). For all staining, no-primary and/or biological negative 
controls (Imp1ΔIEC) were used. Lysozyme scoring was performed according to published 
protocols (Cadwell et al. 2008; Adolph et al. 2013). Scoring of EdU-positive 
“microcolonies”, where a microcolony is defined by a cluster of ≥5 EdU-positive cells 
from a single clone, were quantified, blinded, across at least 30 high-powered fields per 
animal for a total of 4 mice per genotype.  
 
qRT-PCR 
Small intestine crypt RNA was isolated using GeneJet RNA purification kit 
(ThermoFisher). Equal amounts of total RNA were reverse-transcribed using Taqman 
RT Reagents kit and resulting cDNA used with Power SYBR Green PCR Master Mix 
(Applied Biosystems/ThermoFisher) or Taqman Fast Universal PCR Master Mix (Applied 
Biosystems/ThermoFisher) and validated primer sets. Non-reverse transcribed samples 
were used as no RT controls. Gene expression was calculated using R = 2(−ΔΔCt) method, 
where changes in Ct values for the genes of interest were normalized to housekeeping 
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genes. All experiments were replicated in at least 3 independent experiments with 
technical replicates (duplicates).  
 
Western blot  
Caco2 cells or isolated mouse epithelial cells were harvested in western lysis buffer, 
resolved in reducing conditions on 4% to 12% gradient gels, and detected with ECL 
Prime western Blotting Detection Reagent (Amersham; RPN2232). Western blots were 
reproduced in at least three independent experiments.  
 
Flow cytometry 
For analysis of sorted Lgr5-EGFP and Paneth cells, single cell suspensions of crypt-
enriched intestinal epithelium from the entire small intestine of Lgr5-EGFP mice were 
stained on ice for 30 minutes with cKit-PE-Cy7 (1:10; eBioscience) and CD24-PE (1:10, 
Biolegend) to label Paneth cells. DAPI was used to exclude dead cells.  Sorting was 
performed using a FACS Aria II (BD Biosciences) with a 100μm nozzle.  Gating and 
compensation were performed using a negative and single-color controls.  Intestinal 
stem cells were isolated based on Lgr5-EGFP positivity.  Paneth cells were isolated as 
Lgr5-EGFP-negative/cKit-PE-Cy7-positive/CD24-PE-positive/side-scatter high.  RNA 
from Lgr5-ISC, Paneth cells, and non-sorted cells was isolated using the RNAqueous®-
Micro Total RNA Isolation Kit (ThermoFisher). 
 
Transmission electron microscopy 
Mouse small intestine tissues were fixed in cacodylate-buffered 2.5% (w/v) 
glutaraldehyde, post-fixed in 2.0% osmium tetroxide, then embedded in epoxy resin and 
ultrathin sections post-stained in the University of Pennsylvania Electron Microscopy 
Resource Laboratory. Images were obtained using Jeol-1010 transmission electron 
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microscope fitted with a Hamamatsu digital camera and AMT Advantage imaging 
software. A total of 4 mice per genotype were evaluated by two investigators for Paneth 
cell granule morphology (KEH and BJW) (Klionsky et al. 2016). Image contrast was 
enhanced equally in all TEM photos. 
 
Ribonucleoprotein particle (RNP)-immunoprecipitation 
RNP-immunoprecipitations (RIPs) were performed in Caco2 cells using the RiboCluster 
Prolifer™ RIP-Assay Kit (Medical & Biological Laboratories) according to manufacturer’s 
instructions. Anti-IMP1 (MBL RN007P, which targets 561-577aa) or control IgG (supplied 
in kit) were used. Quality control samples for total protein and RNA input as well as 
immunoprecipitated proteins were evaluated for each experiment. Isolated RNA was 
reverse-transcribed as noted above and qPCR performed using the oligonucleotides. 
Raw Ct values from IMP1- and IgG- immunoprecipitated samples were used to 
determine “percent input” for each target, followed by dividing IMP1-immunoprecipitated 
signal by the respective IgG signal. Data for each individual target were then expressed 
as fold-enrichment relative to negative control target TNFRSF1B. Positive controls were 
previously identified IMP1 targets ACTB and PTGS2 (Ross et al. 1997; Manieri et al. 















CHAPTER IV:  SUMMARY 
  
 123 
IMP1 is expressed in proliferating cells and is upregulated during injury 
and disease in the intestinal epithelium 
 
Igf2 mRNA binding protein 1 (IMP1) is an mRNA binding protein identified 
originally as a translational modulator of c-Myc, β-actin, and Igf2 mRNAs. IMP1 is 
expressed ubiquitously during development in mice but has low expression in adult 
tissues. In our studies, we used the Sox9-EGFP mice and Lgr5-EGFP mice to show that 
Imp1 is expressed in the proliferating stem cell compartment in the mouse intestinal 
epithelium. It is not expressed in differentiated cells. Furthermore, we have shown via 
qPCR and western blots that IMP1 is upregulated during radiation injury in mice. IMP1 is 
also upregulated in CRC patient tumors as well as in biopsy samples from Crohn’s 
disease patients. TCGA analysis further corroborates these findings as Imp1 is 
upregulated in more than 80% of colorectal tumors.  
 
IMP1 loss shows global changes in gene expression at the translation and 
transcription levels 
To understand completely the functional effects of RBP expression or deletion, 
evaluation of the protein landscape is required.  In recent years, ribosome footprint 
profiling (RFP) has been developed as a powerful tool to obtain a global snapshot of 
actively translating transcripts within a cell.  This ribosome-centric technique uses 
binding and density of ribosomes on a transcript as an indicator of active translation. 
Profiling is done by deep sequencing of ribosome bound transcripts as well as 
sequencing total RNA abundance. This technique can help distinguish between genes 
regulated at the transcriptome and translatome levels. The ratio of RFP to total mRNA 
abundance for each transcript reveals the translation efficiency for that gene that can be 
compared across genotypes or conditions. 
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Our studies showed that IMP1 loss (both alone and in the context of LIN28B 
overexpression) showed gene expression changes at the transcription and translation 
levels. IMP1 loss regulates expression of genes involved in key signaling pathways such 
as Wnt signaling, TNF signaling, autophagy, cell cycle, mTORC signaling, etc. Hence, 
IMP1 is a key regulator of gene expression in the intestinal epithelium. 
 
IMP1 loss is protective during injury 
We used three different independent models to study the role of IMP1 loss in 
response to injury in mice with intestinal epithelial cell-specific Imp1 deletion using the 
Villin promoter. The VillinCre;Imp1fl/fl mice were subjected to the following three injury 
models : 12 Gy whole body radiation, 2.5% chronic DSS colitis and 5% acute DSS 
colitis. In all three models, VillinCre;Imp1fl/fl mice showed significantly lower weight loss 
as compared to Imp1fl/fl mice controls. The quantification of regenerating Ki67+ 
microcolonies showed significantly increased regeneration in the VillinCre;Imp1fl/fl mice. 
Hence, IMP1 loss was protective in these latter mice. This could be due to the 
upregulation of Wnt signaling and autophagy in these mice. This is further evidenced by 
the finding that knocking out ATG7 in these VillinCre;Imp1fl/fl mice rescues the protective 
phenotype in radiation and acute colitis models. 
 
IMP1 loss increases LIN28B-mediated intestinal tumorigenesis 
Our lab developed mice with LIN28b overexpression in the intestinal epithelial 
cells (Vil-Lin28b). The Vil-Lin28b mice develop adenomas and adenocarcinomas 
between 9-12 months of age.  These lesions are typically invasive unifocal or multifocal 
adenocarcinomas. No adenomas or adenocarcinomas were found in age-matched wild-
type littermates. Thus, Lin28b is sufficient to serve as an oncogene in the small intestine, 
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the first report of this type. This study elucidated the role of IMP1 downstream of LIN28B 
overexpression. IMP1 is upregulated with LIN28B upregulation and IMP1 serves as a 
principle node of gene expression. This study showed that mice with LIN28B 
overexpression and IMP1 loss (Vil-Lin28b; VillinCre;Imp1fl/fl) in the intestinal epithelium 
showed unexpectedly a significant increase in tumor number and higher grade of 
tumors. This is in part due to an increase in Wnt signaling and stem cell signature in the 
intestinal epithelium of these mice. The Vil-Lin28b; VillinCre;Imp1fl/fl mice are also 
protected against radiation injury as compared to Vil-Lin28b mice. 
 
IMP1 overexpression does not initiate tumorigenesis in vivo 
We find that VillinCre;Imp1OE mice do not exhibit spontaneous tumor initiation, 
suggesting that IMP1 overexpression is itself insufficient to drive tumor initiation. 
Furthermore, Villin-Lin28b; VillinCre;Imp1OE mice show no tumors at 12 months of age. 
To that end, it is possible that IMP1 overexpression may serve as a “brake” or 
“checkpoint” to the oncogenic effects of LIN28B. The “checkpoint” regulation may be 
achieved through a variety of mechanisms ascribed to IMP1, such as sequestration of 
transcripts in IMP1 containing RNP granules (Weidensdorfer et al. 2009) (Jonson et al. 
2007 ) (to avoid mRNA degradation and/or release the transcripts for translation at 
critical time points), reduction of miRNA mediated silencing of mRNA transcripts 
(Elcheva et al. 2009; Nishino et al. 2013; Busch et al. 2016; Degrauwe et al. 2016a) (for 
review see (van Kouwenhove et al. 2011)), or displacing miRNA containing RISCs 
(Elcheva et al. 2009). IMP1 may also enhance the expression of LIN28B by shielding 





 To completely understand the function of any RBP in a cell, we need to 
understand what target transcripts it binds to, the context-dependent binding, and 
downstream effect(s) on transcription and translation of the transcript(s). To that end, 
combining CLIP-seq with ribosome profiling or proteomics would provide an even more 
complete functional snapshot for a given RBP. Since IMP1 binds to and regulates 
hundreds of genes, it is difficult to focus on specific genes that regulate functions 
downstream of IMP1, notwithstanding the importance of IMP1 in modulating Wnt 
signaling.  
LIN28B and IMP1 exhibit low expression in most adult tissues, suggesting that 
targeting them may have few deleterious effects. Inhibitors for LIN28B would prevent 
aberrant blockade of tumor suppressor let-7, whereas a specific IMP1 inhibitor would 
require targeting of tumor-promoting interactions while sparing tumor suppressor 
functions. Additionally, our studies evaluate direct binding of IMP1 to several autophagy 
mRNAs. This may help lay the foundation for development of new therapies for the 
selective modulation of autophagy (Kuo et al. 2015; Hooper et al. 2016). Indeed, it may 
be feasible to identify small molecule inhibitors to disrupt IMP1 interactions with specific 
mRNA targets, permitting specific modulation of a desired pathway without disrupting 
other important functional roles (Mahapatra et al. 2014).  Thus, the future may hold 
opportunities to translate the mechanistic and in vivo findings of this thesis into 
translational therapeutics through the employment of 3D enteroids and mouse models. 
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